| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin filament binding | SPTAN1 MYO18B FLNA FLNC FHOD3 ABLIM1 XIRP2 TLN1 KBTBD13 MACF1 TNNC1 ABLIM2 | 2.93e-06 | 227 | 198 | 12 | GO:0051015 |
| GeneOntologyMolecularFunction | actin binding | SPTAN1 MYPN MYO18B FLNA FLNC FHOD3 ABLIM1 XIRP2 TLN1 KBTBD13 MACF1 PRKCE TNNC1 ABLIM2 EPB41L1 MYBPC3 | 2.45e-05 | 479 | 198 | 16 | GO:0003779 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | SPTAN1 PAK4 ITGAV SVEP1 MFGE8 NRXN1 MYPN HSPA5 PLXNB3 FLNA RANGAP1 RARS1 DSP PUF60 IGF1 IGF2 TLN1 MACF1 | 3.08e-05 | 599 | 198 | 18 | GO:0050839 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | EPHB3 SMG1 HK3 PAK4 PRKD3 PIK3C2A CLK1 PI4KB DCLK2 PANK4 HASPIN DCLK3 PRKCE ATM MAP2K2 DCLK1 MAST3 EPHA7 | 2.57e-04 | 709 | 198 | 18 | GO:0016773 |
| GeneOntologyMolecularFunction | protein serine kinase activity | SMG1 PAK4 PRKD3 CLK1 DCLK2 HASPIN DCLK3 PRKCE ATM MAP2K2 DCLK1 MAST3 | 2.85e-04 | 363 | 198 | 12 | GO:0106310 |
| GeneOntologyMolecularFunction | histone H3K27 trimethyltransferase activity | 2.92e-04 | 3 | 198 | 2 | GO:0140951 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 3.28e-04 | 93 | 198 | 6 | GO:0097110 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB3 SMG1 HK3 PAK4 CMAS POLR1H PRKD3 PIK3C2A CLK1 PI4KB DCLK2 OAS2 PANK4 HASPIN DCLK3 PRKCE ATM MAP2K2 DCLK1 MAST3 EPHA7 | 4.30e-04 | 938 | 198 | 21 | GO:0016772 |
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 4.89e-04 | 16 | 198 | 3 | GO:0004697 | |
| GeneOntologyMolecularFunction | kinase activity | EPHB3 SMG1 HK3 PAK4 PRKD3 PIK3C2A CLK1 PI4KB DCLK2 PANK4 HASPIN DCLK3 PRKCE ATM MAP2K2 DCLK1 MAST3 EPHA7 | 6.23e-04 | 764 | 198 | 18 | GO:0016301 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 7.86e-04 | 151 | 198 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 9.34e-04 | 44 | 198 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 9.52e-04 | 76 | 198 | 5 | GO:0098631 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 9.67e-04 | 20 | 198 | 3 | GO:0042800 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | SETX MBNL1 NSRP1 HNRNPF HNRNPH1 HNRNPH2 CLK1 SRSF7 PUF60 NUP98 MBNL2 MBNL3 | 8.00e-07 | 207 | 198 | 12 | GO:0043484 |
| GeneOntologyBiologicalProcess | circulatory system development | EPHB3 HGF PAK4 ARID1A ITGAV SVEP1 STAT3 MFGE8 NRXN1 PIK3C2A CACNA1G C5 MYO18B DNMT1 SLC12A6 FLNA DSP EGLN1 DUSP6 CASP7 FHOD3 SKI ZBTB14 KIF7 IGF1 IGF2 XIRP2 LOXL2 LRP5 ATM TNNC1 MAP2K2 ATP2B4 MYBPC3 | 9.59e-07 | 1442 | 198 | 34 | GO:0072359 |
| GeneOntologyBiologicalProcess | RNA splicing | SETX MBNL1 NSRP1 HNRNPF HNRNPH1 HNRNPH2 SCAF1 CLK1 SUPT6H SRSF7 PUF60 NUP98 SUGP2 MBNL2 ELAVL4 CWF19L1 MBNL3 | 7.50e-06 | 502 | 198 | 17 | GO:0008380 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | SLC25A46 EPHB3 HGF PAK4 ARID1A ITGAV STAT3 MFGE8 NRXN1 PIK3C2A SUPT6H MYPN KDM2B C5 CACNA1A SLC12A6 TMEM182 FLNA FLNC WNT8A EGLN1 APAF1 FHOD3 SKI IGF2 LOXL2 MACF1 ATM MAP2K2 ATP2B4 MYBPC3 | 3.36e-05 | 1483 | 198 | 31 | GO:0048646 |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | SMG1 HGF NRXN1 CLK1 DCLK2 INPP5F DCLK3 PRKCE ATM MAP2K2 DCLK1 MAST3 | 4.38e-05 | 307 | 198 | 12 | GO:0018105 |
| GeneOntologyBiologicalProcess | vasculature development | EPHB3 HGF PAK4 ARID1A ITGAV SVEP1 STAT3 MFGE8 NRXN1 PIK3C2A C5 MYO18B DNMT1 SLC12A6 FLNA EGLN1 ZBTB14 KIF7 IGF1 IGF2 LOXL2 LRP5 ATP2B4 | 5.96e-05 | 969 | 198 | 23 | GO:0001944 |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | SMG1 HGF NRXN1 CLK1 DCLK2 INPP5F DCLK3 PRKCE ATM MAP2K2 DCLK1 MAST3 | 6.34e-05 | 319 | 198 | 12 | GO:0018209 |
| GeneOntologyBiologicalProcess | response to wounding | CADM4 ITGAV F11 SVEP1 STAT3 PROZ VPS33B C5 FLNA RANGAP1 DSP CASP7 INPP5F IGF1 TLN1 MACF1 PRKCE MAP2K2 | 6.97e-05 | 659 | 198 | 18 | GO:0009611 |
| GeneOntologyBiologicalProcess | mRNA processing | SETX MBNL1 NSRP1 HNRNPF HNRNPH1 SCAF1 SUPT6H SRSF7 PUF60 NUP98 SUGP2 MBNL2 ELAVL4 CPSF3 CWF19L1 MBNL3 | 8.83e-05 | 551 | 198 | 16 | GO:0006397 |
| GeneOntologyBiologicalProcess | maintenance of cell number | 1.21e-04 | 242 | 198 | 10 | GO:0098727 | |
| GeneOntologyCellularComponent | Z disc | IGFN1 SPTAN1 MYPN MYO18B FLNA FLNC FHOD3 XIRP2 KBTBD13 ATP2B4 | 1.82e-06 | 151 | 198 | 10 | GO:0030018 |
| GeneOntologyCellularComponent | myofibril | IGFN1 SPTAN1 MYPN MYO18B FLNA FLNC FHOD3 XIRP2 KBTBD13 TNNC1 ABLIM2 ATP2B4 MYBPC3 | 2.18e-06 | 273 | 198 | 13 | GO:0030016 |
| GeneOntologyCellularComponent | contractile muscle fiber | IGFN1 SPTAN1 MYPN MYO18B FLNA FLNC FHOD3 XIRP2 KBTBD13 TNNC1 ABLIM2 ATP2B4 MYBPC3 | 4.23e-06 | 290 | 198 | 13 | GO:0043292 |
| GeneOntologyCellularComponent | I band | IGFN1 SPTAN1 MYPN MYO18B FLNA FLNC FHOD3 XIRP2 KBTBD13 ATP2B4 | 4.28e-06 | 166 | 198 | 10 | GO:0031674 |
| GeneOntologyCellularComponent | sarcomere | IGFN1 SPTAN1 MYPN MYO18B FLNA FLNC FHOD3 XIRP2 KBTBD13 TNNC1 ATP2B4 MYBPC3 | 4.78e-06 | 249 | 198 | 12 | GO:0030017 |
| GeneOntologyCellularComponent | chromatoid body | 5.16e-04 | 17 | 198 | 3 | GO:0033391 | |
| GeneOntologyCellularComponent | alphav-beta3 integrin-IGF-1-IGF1R complex | 5.29e-04 | 4 | 198 | 2 | GO:0035867 | |
| GeneOntologyCellularComponent | apoptosome | 5.29e-04 | 4 | 198 | 2 | GO:0043293 | |
| HumanPheno | Joint contracture | SLC25A46 KDM5B SPTAN1 EZH2 NSRP1 STAT3 UBA1 VPS33B PIK3C2A COG1 MYPN MLH1 TRPV3 MYO18B DSE CACNA1A SLC12A6 FLNA FLNC DSP DUSP6 CPT2 SKI IGF2 KBTBD13 ATM EPB41L1 | 5.38e-06 | 843 | 69 | 27 | HP:0034392 |
| HumanPheno | Flexion contracture | SLC25A46 KDM5B SPTAN1 EZH2 NSRP1 STAT3 UBA1 VPS33B PIK3C2A COG1 MYPN MLH1 TRPV3 MYO18B DSE CACNA1A SLC12A6 FLNA DSP DUSP6 CPT2 SKI IGF2 KBTBD13 ATM EPB41L1 | 9.99e-06 | 817 | 69 | 26 | HP:0001371 |
| HumanPheno | Abnormal tendon morphology | SLC25A46 KDM5B SPTAN1 EZH2 NSRP1 STAT3 UBA1 VPS33B PIK3C2A COG1 MYPN MLH1 TRPV3 MYO18B DSE CACNA1A SLC12A6 FLNA FLNC DSP DUSP6 CPT2 SKI IGF2 KBTBD13 ATM EPB41L1 | 1.11e-05 | 875 | 69 | 27 | HP:0100261 |
| HumanPheno | Abnormal joint physiology | SLC25A46 KDM5B SPTAN1 ARID1A EZH2 NSRP1 HNRNPH1 HNRNPH2 STAT3 UBA1 VPS33B PIK3C2A COG1 MYPN MLH1 TRPV3 MYO18B DSE CACNA1A SLC12A6 FLNA FLNC DSP PUF60 DUSP6 CPT2 SKI KIF7 KMT2D IGF2 KBTBD13 LRP5 ATM MAP2K2 EPB41L1 | 1.56e-05 | 1358 | 69 | 35 | HP:0034430 |
| HumanPheno | Abnormality of joint mobility | SLC25A46 KDM5B SPTAN1 ARID1A EZH2 NSRP1 HNRNPH1 HNRNPH2 STAT3 UBA1 VPS33B PIK3C2A COG1 MYPN MLH1 TRPV3 MYO18B DSE CACNA1A SLC12A6 FLNA FLNC DSP PUF60 DUSP6 CPT2 SKI KIF7 KMT2D IGF2 KBTBD13 LRP5 ATM MAP2K2 EPB41L1 | 1.56e-05 | 1358 | 69 | 35 | HP:0011729 |
| HumanPheno | Feeding difficulties | SETX ARID1A EZH2 NSRP1 STAT3 UBA1 COG1 TRAPPC6B MYPN CACNA1G CACNA1A FLNA FLNC RARS1 PUF60 CPT2 SKI KIF7 KMT2D IGF2 GUCY1A1 KBTBD13 LRP5 MACF1 HSD17B10 MAP2K2 TOP3A EPB41L1 | 3.22e-05 | 982 | 69 | 28 | HP:0002022 |
| HumanPheno | Abnormal esophagus physiology | SETX SPTAN1 NSRP1 HNRNPH1 HNRNPH2 STAT3 NRXN1 TRAPPC6B MYPN CACNA1G CACNA1A FLNA FLNC RARS1 DSP PUF60 MUC5B SKI KMT2D GUCY1A1 KBTBD13 LRP5 MACF1 HSD17B10 MAP2K2 CPSF3 TOP3A | 3.70e-05 | 933 | 69 | 27 | HP:0025270 |
| Domain | Znf_CHHC | 1.12e-06 | 3 | 195 | 3 | IPR012996 | |
| Domain | zf-RNPHF | 1.12e-06 | 3 | 195 | 3 | PF08080 | |
| Domain | PI3/4_kinase_CS | 1.44e-05 | 15 | 195 | 4 | IPR018936 | |
| Domain | Kinase-like_dom | EPHB3 SMG1 PAK4 PRKD3 PIK3C2A CLK1 PI4KB DCLK2 CHD9 HASPIN DCLK3 MACF1 PRKCE ATM MAP2K2 DCLK1 MAST3 EPHA7 | 1.60e-05 | 542 | 195 | 18 | IPR011009 |
| Domain | PI3Kc | 1.90e-05 | 16 | 195 | 4 | SM00146 | |
| Domain | - | 1.90e-05 | 16 | 195 | 4 | 1.10.1070.11 | |
| Domain | PI3/4_kinase_cat_dom | 3.14e-05 | 18 | 195 | 4 | IPR000403 | |
| Domain | PI3_PI4_kinase | 3.14e-05 | 18 | 195 | 4 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 3.14e-05 | 18 | 195 | 4 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 3.14e-05 | 18 | 195 | 4 | PS00916 | |
| Domain | PI3_4_KINASE_3 | 3.14e-05 | 18 | 195 | 4 | PS50290 | |
| Domain | Insulin-like_growth_factor | 1.08e-04 | 2 | 195 | 2 | IPR022350 | |
| Domain | ATM/Tel1 | 1.08e-04 | 2 | 195 | 2 | IPR015519 | |
| Domain | Ephrin_rec_like | 1.74e-04 | 11 | 195 | 3 | PF07699 | |
| Domain | RRM_1 | SETD1B HNRNPF HNRNPH1 MYEF2 HNRNPH2 ENOX2 SRSF7 PUF60 ELAVL4 | 3.47e-04 | 208 | 195 | 9 | PF00076 |
| Domain | RRM | SETD1B HNRNPF HNRNPH1 MYEF2 HNRNPH2 ENOX2 SRSF7 PUF60 ELAVL4 | 4.72e-04 | 217 | 195 | 9 | SM00360 |
| Domain | Post-SET_dom | 5.68e-04 | 16 | 195 | 3 | IPR003616 | |
| Domain | PostSET | 5.68e-04 | 16 | 195 | 3 | SM00508 | |
| Domain | POST_SET | 5.68e-04 | 16 | 195 | 3 | PS50868 | |
| Domain | AbLIM_anchor | 6.42e-04 | 4 | 195 | 2 | PF16182 | |
| Domain | AbLIM_anchor | 6.42e-04 | 4 | 195 | 2 | IPR032402 | |
| Domain | RRM_dom | SETD1B HNRNPF HNRNPH1 MYEF2 HNRNPH2 ENOX2 SRSF7 PUF60 ELAVL4 | 6.53e-04 | 227 | 195 | 9 | IPR000504 |
| Domain | RRM | SETD1B HNRNPF HNRNPH1 MYEF2 HNRNPH2 ENOX2 SRSF7 PUF60 ELAVL4 | 7.17e-04 | 230 | 195 | 9 | PS50102 |
| Pathway | WP_MRNA_PROCESSING | MBNL1 RPS11 RO60 HNRNPF HNRNPH1 MYEF2 HNRNPH2 CLK1 PUM3 TMED10 ENOX2 SRSF7 PUF60 OAS2 SUGP2 ADAM5 EIF4E ELAVL4 CPSF3 | 1.04e-06 | 451 | 162 | 19 | MM15946 |
| Pathway | KEGG_AXON_GUIDANCE | 1.77e-05 | 129 | 162 | 9 | M5539 | |
| Pathway | BIOCARTA_CHEMICAL_PATHWAY | 4.54e-05 | 18 | 162 | 4 | M3873 | |
| Pathway | KEGG_PRION_DISEASES | 4.63e-05 | 35 | 162 | 5 | M13036 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PSMA3 SPTAN1 RPS11 RO60 SRPRB HNRNPF HNRNPH1 SCAF1 MFGE8 UBA1 VPS33B SUPT6H STARD9 UCHL5 PUM3 MYO18B HSPA5 DNMT1 GPD2 FLNA RANGAP1 RARS1 SRSF7 DSP PUF60 OTUB1 SMC6 NUP98 CASP7 LAP3 GBA3 TLN1 EIF4E HSD17B10 ATM CPSF3 | 5.14e-14 | 1425 | 198 | 36 | 30948266 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETX SETD1B PSMA3 SPTAN1 RPS11 ARID1A CMAS SRPRB HNRNPF HNRNPH1 MYEF2 HNRNPH2 ACSL1 UBA1 VPS33B PIK3C2A UBR5 MLH1 PUM3 HSPA5 RAB13 DNMT1 FLNA FLNC RANGAP1 RARS1 DSP GNPNAT1 RHOT2 SUGP2 TLN1 GSDMA MACF1 CPSF3 TP53BP1 | 6.11e-14 | 1353 | 198 | 35 | 29467282 |
| Pubmed | SMG1 PRKD3 PIK3C2A CLK1 SUPT6H TAX1BP1 MYPN PUM3 MYO18B MED13 SLC12A6 FLNC AMPD1 UACA DSP ABLIM1 XIRP2 TLN1 MACF1 ABLIM2 | 1.08e-11 | 497 | 198 | 20 | 23414517 | |
| Pubmed | PSMA3 SPTAN1 RPS11 HNRNPF HNRNPH1 STAT3 UBA1 SUPT6H HSPA5 FLNA RANGAP1 RARS1 SRSF7 PUF60 NUP98 SUGP2 TLN1 HSD17B10 LRBA MAP2K2 CPSF3 IPO11 | 1.93e-11 | 638 | 198 | 22 | 33239621 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RPS11 SRPRB HNRNPF HNRNPH1 MYEF2 HNRNPH2 SCAF1 UBA1 UBR5 SUPT6H PUM3 HSPA5 GPD2 FLNA FLNC RANGAP1 RARS1 SRSF7 DSP PUF60 NUP98 KIF7 ABLIM1 SUGP2 TLN1 MACF1 HSD17B10 | 4.00e-11 | 1024 | 198 | 27 | 24711643 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | PSMA3 RPS11 ARID1A CMAS HNRNPF HNRNPH2 UBA1 PIK3C2A TMED10 HSPA5 RAB13 DNMT1 GPD2 FLNA FLNC AMPD1 RANGAP1 SRSF7 DSP PUF60 OTUB1 NUP98 MUC5B LAP3 ABLIM1 TLN1 GSDMA HSD17B10 CPSF3 TP53BP1 IPO11 | 5.50e-11 | 1367 | 198 | 31 | 32687490 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PSMA3 SPTAN1 EZH2 HNRNPF HNRNPH1 SCAF1 UBA1 KDM2B MED13 DNMT1 FLNA RANGAP1 SRSF7 UACA DSP NELFA NUP98 ABLIM1 KMT2D SUGP2 ATM MAP2K2 TP53BP1 | 1.25e-10 | 774 | 198 | 23 | 15302935 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | KDM5B SETX SPTAN1 ARID1A CMAS NSRP1 HNRNPF HNRNPH1 MYEF2 HNRNPH2 NSD3 NRXN1 CLK1 SUPT6H HSPA5 GPD2 FLNC RANGAP1 SRSF7 DSP PUF60 CHD9 ZCCHC4 SUGP2 MACF1 ATM CPSF3 | 1.36e-10 | 1082 | 198 | 27 | 38697112 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 MBNL1 NCAM2 ARID1A NSRP1 HNRNPF SUPT6H DCLK2 NCK2 MICOS10 SLC12A6 UACA CHD9 SKI SLC7A1 ABLIM1 IGF1 IGF2 SUGP2 MBNL2 GUCY1A1 LOXL2 PANK4 LRP5 MACF1 PRKCE LRBA ABLIM2 HSD17B14 MAP2K2 EPB41L1 | 4.45e-10 | 1489 | 198 | 31 | 28611215 |
| Pubmed | SPTAN1 ARID1A STAT3 NSD3 UBA1 KDM2B HSPA5 DNMT1 FLNA RANGAP1 RARS1 DSP PUF60 ABLIM1 KMT2D SUGP2 TLN1 LRBA TP53BP1 | 4.61e-10 | 549 | 198 | 19 | 38280479 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RPS11 CMAS NSRP1 HNRNPF HNRNPH1 HNRNPH2 SCAF1 UBA1 SUPT6H PUM3 HSPA5 DNMT1 GPD2 FLNA FLNC RARS1 SRSF7 DSP OTUB1 RHOT2 LAP3 SUGP2 HSD17B10 CPSF3 TP53BP1 | 5.36e-10 | 989 | 198 | 25 | 36424410 |
| Pubmed | SPTAN1 RPS11 NCAM2 ARID1A CMAS HNRNPF HNRNPH1 MYEF2 UBA1 DCLK2 HSPA5 NCK2 GPD2 CACNA1A SLC12A6 FLNA FLNC SRSF7 DSP ARHGEF12 ABLIM1 SUGP2 TLN1 EIF4E MACF1 PRKCE ABLIM2 ATP2B4 DCLK1 EPB41L1 | 7.49e-10 | 1431 | 198 | 30 | 37142655 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | PAK4 RPS11 NSRP1 HNRNPF HNRNPH1 STAT3 UBA1 MLH1 DNMT1 FLNA RANGAP1 DSP PUF60 EGLN1 NUP98 SPAG5 ABLIM1 SUGP2 TLN1 MACF1 SLFN11 LRBA CPSF3 TP53BP1 | 8.84e-10 | 934 | 198 | 24 | 33916271 |
| Pubmed | SETD1B SPTAN1 RPS11 SRPRB HNRNPF HNRNPH1 HNRNPH2 C9 HSPA5 DNMT1 FLNA RARS1 SRSF7 DSP PUF60 NUP98 KMT2D TLN1 EIF4E MACF1 MAP2K2 | 9.34e-10 | 711 | 198 | 21 | 33022573 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SETX SPTAN1 PAK4 ARID1A HNRNPF HNRNPH1 VPS33B UCHL5 MLH1 HSPA5 RANGAP1 SRSF7 DSP PUF60 TLN1 MACF1 ATM MAP2K2 CPSF3 | 1.21e-09 | 582 | 198 | 19 | 20467437 |
| Pubmed | SPTAN1 ARID1A HNRNPF MYEF2 UBR5 SUPT6H PUM3 DNMT1 FLNA FLNC RANGAP1 DSP PUF60 NUP98 SUGP2 TLN1 MACF1 ATM CPSF3 TP53BP1 | 1.29e-09 | 653 | 198 | 20 | 22586326 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | PSMA3 SPTAN1 RPS11 HNRNPF HNRNPH1 MYEF2 CACNA1G HSPA5 GPD2 FLNA FLNC RARS1 DSP PUF60 GNPNAT1 MUC5B SPAG5 GET4 TLN1 MACF1 HSD17B10 LRBA | 1.60e-09 | 807 | 198 | 22 | 30575818 |
| Pubmed | SETX PSMA3 MBNL1 ARID1A ACSL1 UBA1 UBR5 PUM3 TMED10 DNMT1 FLNA RARS1 SRSF7 PUF60 NELFA OTUB1 CHD9 KMT2D GET4 SUGP2 TLN1 EIF4E SLFN11 TP53BP1 IPO11 | 4.84e-09 | 1103 | 198 | 25 | 34189442 | |
| Pubmed | PAK4 RPS11 SRPRB HNRNPF HNRNPH1 STAT3 UBA1 HSPA5 NCK2 GPD2 RANGAP1 DSP EGLN1 ARHGEF12 ABLIM1 TLN1 MACF1 HSD17B10 LRBA EPB41L1 | 5.09e-09 | 708 | 198 | 20 | 39231216 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | PSMA3 SPTAN1 RPS11 HNRNPF HNRNPH1 UBA1 UBR5 UCHL5 TMED10 HSPA5 FLNA FLNC RANGAP1 RARS1 DSP PUF60 OTUB1 CPT2 LAP3 TLN1 EIF4E PANK4 MACF1 HSD17B10 SLFN11 | 1.09e-08 | 1149 | 198 | 25 | 35446349 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | PSMA3 SPTAN1 PAK4 NSRP1 HNRNPF HNRNPH2 CLK1 MED13 NCK2 ENOX2 RANGAP1 SRSF7 DUSP6 SKI SUGP2 DCLK3 ATP2B4 EPB41L1 MBNL3 | 2.11e-08 | 695 | 198 | 19 | 23602568 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SETX RPS11 ARID1A EZH2 CMAS SRPRB HNRNPF HNRNPH1 HNRNPH2 NSD3 SCAF1 SUPT6H UCHL5 KDM2B HSPA5 DNMT1 RANGAP1 SRSF7 DSP NUP98 SKI ZBTB14 KMT2D NOM1 CPSF3 TOP3A | 2.68e-08 | 1294 | 198 | 26 | 30804502 |
| Pubmed | SPTAN1 RPS11 HNRNPF HNRNPH1 HNRNPH2 UBA1 UCHL5 HSPA5 FLNA FLNC RANGAP1 RARS1 DSP CHD9 TLN1 TP53BP1 | 2.89e-08 | 494 | 198 | 16 | 26831064 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | SPTAN1 MBNL1 RPS11 NSRP1 HNRNPF SVEP1 HNRNPH1 MYEF2 HNRNPH2 UBA1 CLK1 PUM3 HSPA5 FLNA SRSF7 PUF60 SUGP2 HSD17B10 CPSF3 | 3.23e-08 | 714 | 198 | 19 | 28302793 |
| Pubmed | RPS11 SRPRB HNRNPH1 TMED10 HSPA5 GPD2 FLNA FLNC RARS1 DSP TLN1 GSDMA HSD17B10 | 3.33e-08 | 312 | 198 | 13 | 37120454 | |
| Pubmed | SPTAN1 MYEF2 UBA1 NRXN1 UBR5 TAX1BP1 TMED10 DNMT1 CACNA1A RANGAP1 UACA ARHGEF12 GRM4 KIF7 ABLIM1 MACF1 ELAVL4 PRKCE ATP2B4 DCLK1 EPB41L1 TP53BP1 | 3.79e-08 | 963 | 198 | 22 | 28671696 | |
| Pubmed | SPTAN1 PAK4 ARID1A NSD3 UBA1 VPS33B UCHL5 PPM1L MLH1 HSPA5 NCK2 DNMT1 GPD2 RANGAP1 DSP DUSP6 NUP98 KIF7 KMT2D SLFN11 CPSF3 ATP2B4 EPB41L1 | 3.83e-08 | 1049 | 198 | 23 | 27880917 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SPTAN1 PAK4 MBNL1 SRPRB UBA1 PIK3C2A FLNA FLNC RANGAP1 UACA EGLN1 SMC6 SUGP2 MBNL2 NOM1 TLN1 EIF4E MACF1 HSD17B10 | 4.02e-08 | 724 | 198 | 19 | 36232890 |
| Pubmed | RPS11 ARID1A EZH2 SRPRB HNRNPF MYEF2 STAT3 UBA1 TMED10 HSPA5 RAB13 FLNA RARS1 SRSF7 DSP LAP3 NOM1 TLN1 MAP2K2 DCLK1 | 4.08e-08 | 803 | 198 | 20 | 36517590 | |
| Pubmed | SPTAN1 RPS11 ARID1A CMAS HNRNPF HNRNPH1 PIK3C2A TAX1BP1 MLH1 KDM2B HSPA5 RAB13 MED13 FLNA RANGAP1 RARS1 SRSF7 UACA PUF60 NUP98 CHD9 ABLIM1 TLN1 HSD17B10 MAP2K2 | 5.30e-08 | 1247 | 198 | 25 | 27684187 | |
| Pubmed | SMG1 PSMA3 SPTAN1 SRPRB STAT3 PIK3C2A UBR5 COG1 TRAPPC6B PUM3 TMED10 GPD2 FLNA RANGAP1 SRSF7 UACA OTUB1 CASP7 RHOT2 SPAG5 ABLIM1 NOM1 TLN1 PANK4 HSD17B10 ATM IPO11 | 5.79e-08 | 1440 | 198 | 27 | 30833792 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PSMA3 SPTAN1 RPS11 RO60 HNRNPF HNRNPH1 STAT3 UBA1 UCHL5 HSPA5 FLNA FLNC RANGAP1 RARS1 PUF60 NUP98 CASP7 LAP3 GET4 TLN1 EIF4E PANK4 MACF1 HSD17B10 LRBA EPB41L1 IPO11 | 7.14e-08 | 1455 | 198 | 27 | 22863883 |
| Pubmed | SPTAN1 PAK4 RPS11 RO60 SRPRB HNRNPF HNRNPH1 HSPA5 FLNA RARS1 SRSF7 DSP RHOT2 HSD17B10 SLFN11 | 7.93e-08 | 463 | 198 | 15 | 34901782 | |
| Pubmed | SETX PSMA3 SPTAN1 ITGAV SRPRB STAT3 PRKD3 SCAF1 PIK3C2A STARD9 UCHL5 TAX1BP1 PUM3 C5 DNMT1 FLNA RARS1 SRSF7 UACA DSP PUF60 SUGP2 NOM1 TLN1 ATP2B4 MBNL3 | 8.37e-08 | 1371 | 198 | 26 | 36244648 | |
| Pubmed | ARID1A MYEF2 UBR5 ENOX2 RMND5B RANGAP1 CHD9 SUGP2 NOM1 MACF1 HSD17B10 SLFN11 | 9.05e-08 | 282 | 198 | 12 | 23667531 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | PSMA3 SPTAN1 RPS11 ARID1A HNRNPH1 SUPT6H TMED10 HSPA5 DNMT1 RMND5B FLNA FLNC RANGAP1 RARS1 DSP TLN1 LRP5 MACF1 HSD17B10 ATP2B4 | 9.66e-08 | 847 | 198 | 20 | 35235311 |
| Pubmed | SETX SPTAN1 RPS11 ITGAV SRPRB HNRNPH2 STAT3 NSD3 UBA1 UBR5 TAX1BP1 MLH1 TMED10 HSPA5 RAB13 DNMT1 FLNA RARS1 SRSF7 DSP OTUB1 LOXL2 MACF1 CPSF3 TP53BP1 | 1.12e-07 | 1297 | 198 | 25 | 33545068 | |
| Pubmed | SETD1B HNRNPF HNRNPH1 MYEF2 HNRNPH2 SUPT6H ENOX2 SRSF7 NUP98 ZCCHC4 ADAM5 ELAVL4 TOP3A | 1.14e-07 | 347 | 198 | 13 | 16033648 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SETX MBNL1 ARID1A NSRP1 HNRNPF HNRNPH1 NSD3 PUM3 HSPA5 DNMT1 FLNA RANGAP1 SRSF7 DSP PUF60 SMC6 NUP98 SUGP2 MBNL2 HSD17B10 TP53BP1 | 1.46e-07 | 954 | 198 | 21 | 36373674 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MBNL1 RPS11 RO60 SRPRB HNRNPF POLR1H HNRNPH1 HNRNPH2 STAT3 SCAF1 TMED10 HSPA5 RAB13 DNMT1 FLNA RARS1 SRSF7 PUF60 NUP98 LAP3 HSD17B10 LRBA MAP2K2 CPSF3 IPO11 | 1.51e-07 | 1318 | 198 | 25 | 30463901 |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | SPTAN1 HNRNPF RAB13 FLNA FLNC RANGAP1 OTUB1 ABLIM1 NUDT3 TLN1 PANK4 ELAVL4 ATM MAP2K2 DCLK1 EPB41L1 | 1.52e-07 | 558 | 198 | 16 | 35063084 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | PSMA3 SPTAN1 RPS11 SRPRB HNRNPF HNRNPH1 HNRNPH2 STAT3 UBA1 UBR5 SUPT6H HSPA5 DNMT1 GPD2 FLNA RANGAP1 RARS1 SRSF7 DSP PUF60 SPAG5 TLN1 EIF4E MACF1 HSD17B10 CWF19L1 | 1.55e-07 | 1415 | 198 | 26 | 28515276 |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | PSMA3 HNRNPF HNRNPH1 UBA1 UBR5 MLH1 HSPA5 FLNA RANGAP1 RARS1 DSP SUGP2 GSDMA | 1.59e-07 | 357 | 198 | 13 | 37059091 |
| Pubmed | RO60 ARID1A EZH2 CMAS UBA1 UBR5 MLH1 PUM3 NELFA MUC5B SPAG5 LOXL2 NOM1 TLN1 MACF1 ATP2B4 EPB41L1 | 1.59e-07 | 634 | 198 | 17 | 34591612 | |
| Pubmed | SPTAN1 NSRP1 HNRNPF HNRNPH1 ACSL1 UBA1 MLH1 FLNA FLNC NUP98 TLN1 MACF1 TP53BP1 | 1.74e-07 | 360 | 198 | 13 | 33111431 | |
| Pubmed | 1.82e-07 | 3 | 198 | 3 | 7499401 | ||
| Pubmed | Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle. | 1.82e-07 | 3 | 198 | 3 | 19095965 | |
| Pubmed | Loss of MBNL1 induces RNA misprocessing in the thymus and peripheral blood. | 1.82e-07 | 3 | 198 | 3 | 32332745 | |
| Pubmed | 1.82e-07 | 3 | 198 | 3 | 14980514 | ||
| Pubmed | 1.82e-07 | 3 | 198 | 3 | 11929853 | ||
| Pubmed | 1.82e-07 | 3 | 198 | 3 | 15257297 | ||
| Pubmed | Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy. | 1.82e-07 | 3 | 198 | 3 | 28698297 | |
| Pubmed | 1.82e-07 | 3 | 198 | 3 | 10456323 | ||
| Pubmed | 1.82e-07 | 3 | 198 | 3 | 25263597 | ||
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | PSMA3 SPTAN1 RPS11 HNRNPF HNRNPH1 UBA1 UCHL5 HSPA5 FLNA RANGAP1 RARS1 UACA PUF60 LAP3 HSD17B10 | 1.87e-07 | 495 | 198 | 15 | 28581483 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SMG1 MBNL1 HNRNPF HNRNPH1 MYEF2 HNRNPH2 UBA1 SUPT6H PUM3 FLNA SRSF7 PUF60 SUGP2 MBNL2 NOM1 EIF4E MACF1 HSD17B10 MBNL3 | 2.15e-07 | 807 | 198 | 19 | 22681889 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | SPTAN1 RPS11 STAT3 MYPN FLNA RANGAP1 RARS1 DSP NUP98 SPAG5 TLN1 | 2.86e-07 | 256 | 198 | 11 | 33397691 |
| Pubmed | SPTAN1 PAK4 ARID1A SRPRB VPS33B PIK3C2A UBR5 PI4KB NELFA INPP5F KIF7 ABLIM1 MAP2K2 IPO11 | 3.18e-07 | 446 | 198 | 14 | 24255178 | |
| Pubmed | SETX PSMA3 ARID1A UBA1 DNMT1 FLNC TDRD1 LAP3 TLN1 EIF4E TNNC1 | 3.21e-07 | 259 | 198 | 11 | 31162944 | |
| Pubmed | 3.26e-07 | 11 | 198 | 4 | 21900255 | ||
| Pubmed | SMG1 SVEP1 TINAGL1 UBR5 TAX1BP1 RMND5B FLNA FLNC OTUB1 RHOT2 SKI TXNIP KMT2D NOM1 LRP5 MACF1 | 3.28e-07 | 591 | 198 | 16 | 15231748 | |
| Pubmed | KDM5B PSMA3 SPTAN1 NCAM2 ARID1A CMAS HNRNPF STAT3 MFGE8 COG1 CLK1 DCLK2 HSPA5 MED13 PLXNB3 DNMT1 DSP CHD9 TRIM5 ABLIM1 MACF1 ATM LRBA DCLK1 | 3.62e-07 | 1285 | 198 | 24 | 35914814 | |
| Pubmed | PKD1L2 SVEP1 HNRNPH1 UBA1 COG1 UCHL5 HSPA5 FLNA DSP OTUB1 TLN1 MACF1 | 3.76e-07 | 322 | 198 | 12 | 26514267 | |
| Pubmed | SPTAN1 PAK4 CMAS SRPRB NSRP1 PIK3C2A UBR5 SUPT6H TMED10 HSPA5 DNMT1 RANGAP1 UACA OTUB1 APAF1 KIF7 TLN1 PANK4 MACF1 HSD17B10 ATM ATP2B4 EPB41L1 TP53BP1 MAST3 EPHA7 | 3.99e-07 | 1487 | 198 | 26 | 33957083 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | PSMA3 RPS11 ITGAV F11 MFGE8 UBA1 PROZ PIK3C2A C5 C9 HSPA5 RAB13 FLNA RARS1 UACA DSP OTUB1 APAF1 ARHGEF12 LAP3 TLN1 | 4.09e-07 | 1016 | 198 | 21 | 19056867 |
| Pubmed | RPS11 NSRP1 HNRNPF HNRNPH2 DNMT1 FLNA RARS1 SRSF7 UACA PUF60 OTUB1 TXNIP SUGP2 NOM1 MACF1 CWF19L1 | 4.10e-07 | 601 | 198 | 16 | 33658012 | |
| Pubmed | SPTAN1 HNRNPH1 HNRNPH2 UBR5 SUPT6H UCHL5 HSPA5 RANGAP1 PUF60 NELFA SLFN11 MAP2K2 IPO11 | 4.33e-07 | 390 | 198 | 13 | 17643375 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KDM5B SETX SPTAN1 PAK4 STAT3 NSD3 PIK3C2A STARD9 PI4KB DCLK2 DNMT1 DSP INPP5F ABLIM1 MACF1 PRKCE MAP2K2 DCLK1 EPB41L1 | 5.70e-07 | 861 | 198 | 19 | 36931259 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | SMG1 SPTAN1 RPS11 HNRNPF HNRNPH1 MFGE8 TAX1BP1 HSPA5 RAB13 FLNA SRSF7 UACA DSP ABLIM1 GET4 TOP3A | 7.01e-07 | 626 | 198 | 16 | 33644029 |
| Pubmed | 7.24e-07 | 4 | 198 | 3 | 17591929 | ||
| Pubmed | 7.24e-07 | 4 | 198 | 3 | 38874740 | ||
| Pubmed | 7.24e-07 | 4 | 198 | 3 | 26501102 | ||
| Pubmed | Developmental expression of mouse muscleblind genes Mbnl1, Mbnl2 and Mbnl3. | 7.24e-07 | 4 | 198 | 3 | 12915312 | |
| Pubmed | 7.24e-07 | 4 | 198 | 3 | 32738303 | ||
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | RPS11 RO60 SRPRB HNRNPF HNRNPH1 HNRNPH2 UBA1 HSPA5 FLNA RANGAP1 RARS1 NUP98 | 7.56e-07 | 344 | 198 | 12 | 36282215 |
| Pubmed | PSMA3 SRPRB UBA1 COG1 UCHL5 HSPA5 GPD2 FLNA RANGAP1 RARS1 DSP OTUB1 LAP3 GET4 TLN1 HSD17B10 LRBA MAP2K2 IPO11 | 7.63e-07 | 878 | 198 | 19 | 37223481 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | SETX PSMA3 SPTAN1 RPS11 HNRNPF HNRNPH1 HNRNPH2 HSPA5 FLNA FLNC RARS1 DSP ABLIM1 EIF4E GSDMA | 8.46e-07 | 558 | 198 | 15 | 27591049 |
| Pubmed | SETX SPTAN1 PAK4 NSD3 HSPA5 FLNA FLNC DSP NUP98 ABLIM1 MACF1 PRKCE ABLIM2 MAP2K2 | 8.84e-07 | 486 | 198 | 14 | 20936779 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SPTAN1 RPS11 CMAS SRPRB HNRNPF HNRNPH1 HNRNPH2 NSD3 UBA1 PUM3 C9 HSPA5 DNMT1 FLNA RARS1 SRSF7 UACA DSP PUF60 NUP98 ABLIM1 NOM1 GSDMA | 9.18e-07 | 1257 | 198 | 23 | 36526897 |
| Pubmed | PSMA3 SPTAN1 RPS11 ITGAV HNRNPH1 HNRNPH2 HSPA5 FLNA FLNC RARS1 DSP PUF60 TLN1 MACF1 | 9.28e-07 | 488 | 198 | 14 | 31324722 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SPTAN1 PAK4 HSPA5 NCK2 FLNA RANGAP1 RARS1 UACA PUF60 ARHGEF12 ABLIM1 TLN1 MACF1 ATP2B4 EPB41L1 | 9.88e-07 | 565 | 198 | 15 | 25468996 |
| Pubmed | SPTAN1 RPS11 SRPRB HNRNPF HNRNPH1 HNRNPH2 TMED10 HSPA5 RAB13 GET4 | 1.28e-06 | 239 | 198 | 10 | 23246001 | |
| Pubmed | PSMA3 SRPRB NSRP1 HNRNPF UBR5 TMED10 HSPA5 FLNA RANGAP1 RARS1 DSP SLC7A1 ABLIM1 GET4 NOM1 IPO11 | 1.31e-06 | 657 | 198 | 16 | 36180527 | |
| Pubmed | PSMA3 CMAS STAT3 NSD3 UBA1 UBR5 SUPT6H UCHL5 MED13 DNMT1 PUF60 NELFA OTUB1 SMC6 NUP98 CHD9 SUGP2 ATM CPSF3 CWF19L1 | 1.60e-06 | 1014 | 198 | 20 | 32416067 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SMG1 SETD1B ARID1A HNRNPF HNRNPH1 MYEF2 HNRNPH2 UBR5 SUPT6H PUM3 NUP98 HASPIN TP53BP1 | 1.66e-06 | 440 | 198 | 13 | 34244565 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | ARID1A NSRP1 ACSL1 UBR5 SUPT6H FLNA SRSF7 PUF60 OTUB1 NUP98 LAP3 NOM1 SLFN11 MAP2K2 CPSF3 TP53BP1 | 1.69e-06 | 670 | 198 | 16 | 22990118 |
| Pubmed | PSMA3 SPTAN1 HNRNPF HNRNPH1 HNRNPH2 UBA1 RANGAP1 DSP LAP3 HSD17B10 | 1.78e-06 | 248 | 198 | 10 | 32963011 | |
| Pubmed | BDP1 SETX SPTAN1 HNRNPF HNRNPH2 HSPA5 FLNA NUP98 SLFN11 TP53BP1 | 1.91e-06 | 250 | 198 | 10 | 33536335 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | SPTAN1 RPS11 RO60 HNRNPF HNRNPH1 MYEF2 HNRNPH2 HSPA5 FLNA SRSF7 DSP PUF60 ZCCHC4 SUGP2 NOM1 HSD17B10 | 1.97e-06 | 678 | 198 | 16 | 30209976 |
| Pubmed | 1.97e-06 | 65 | 198 | 6 | 34645483 | ||
| Pubmed | PSMA3 SRPRB HNRNPF HNRNPH1 COG1 STARD9 HSPA5 FLNA RANGAP1 ARHGEF12 TLN1 LRBA CPSF3 | 2.07e-06 | 449 | 198 | 13 | 31732153 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | PSMA3 RO60 SRPRB UBR5 COG1 UCHL5 TMED10 DNMT1 FLNA RANGAP1 RARS1 NUP98 RHOT2 SPAG5 SLC7A1 GET4 TLN1 ATP2B4 IPO11 | 2.14e-06 | 942 | 198 | 19 | 31073040 |
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 2.17e-06 | 147 | 198 | 8 | 28977470 | |
| Pubmed | SPTAN1 RPS11 RO60 CMAS HNRNPF HNRNPH1 HSPA5 RARS1 NOM1 HSD17B10 TOP3A IPO11 | 2.31e-06 | 383 | 198 | 12 | 29331416 | |
| Pubmed | AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis. | 2.41e-06 | 200 | 198 | 9 | 35546148 | |
| Pubmed | A targeted proteomic analysis of the ubiquitin-like modifier nedd8 and associated proteins. | 2.45e-06 | 38 | 198 | 5 | 18247557 | |
| Pubmed | SPTAN1 CMAS SRPRB MYEF2 HNRNPH2 UBA1 NRXN1 DCLK2 CACNA1A FLNA RANGAP1 RARS1 DSP ABLIM1 SUGP2 MACF1 ELAVL4 HSD17B10 DCLK1 EPB41L1 TP53BP1 | 2.51e-06 | 1139 | 198 | 21 | 36417873 | |
| Pubmed | PSMA3 HNRNPH1 HNRNPH2 UBA1 UBR5 UCHL5 TMED10 HSPA5 FLNA RARS1 NUP98 LAP3 GET4 MAP2K2 | 2.65e-06 | 534 | 198 | 14 | 35032548 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | SLC25A46 PSMA3 MBNL1 HNRNPF HNRNPH1 MYEF2 HNRNPH2 PRKD3 DENND6A SUGP2 MBNL2 EIF4E ELAVL4 | 2.83e-06 | 462 | 198 | 13 | 31138677 |
| Pubmed | EPHB3 PSMA3 MBNL1 RPS11 HNRNPF HNRNPH1 HNRNPH2 UBR5 TMED10 HSPA5 SRSF7 PUF60 GET4 | 2.90e-06 | 463 | 198 | 13 | 27503909 | |
| Interaction | YWHAZ interactions | BDP1 KDM5B SPTAN1 PAK4 NCAM2 ARID1A EZH2 UBA1 NRXN1 PIK3C2A STARD9 UCHL5 PI4KB TAX1BP1 PUM3 HSPA5 DNMT1 UACA PUF60 NELFA INPP5F SPAG5 ABLIM1 MCTP1 LOXL2 GSDMA MACF1 PRKCE SLFN11 ATM MAP2K2 CWF19L1 DCLK1 EPB41L1 TP53BP1 MAST3 | 1.55e-08 | 1319 | 196 | 36 | int:YWHAZ |
| Interaction | SNW1 interactions | SPTAN1 PAK4 ARID1A EZH2 HNRNPF HNRNPH1 UBA1 VPS33B UBR5 UCHL5 MLH1 HSPA5 NCK2 FLNA RANGAP1 SRSF7 DSP PUF60 MUC5B SKI TLN1 EIF4E ATM MAP2K2 CPSF3 CWF19L1 | 1.82e-08 | 747 | 196 | 26 | int:SNW1 |
| Interaction | BRCA1 interactions | HGF SETX SPTAN1 RPS11 RO60 ARID1A EZH2 CMAS HNRNPF HNRNPH1 HNRNPH2 STAT3 UBA1 UBR5 SUPT6H UCHL5 MLH1 HSPA5 DNMT1 FLNA FLNC RANGAP1 RARS1 DSP SMC6 CHD9 ZBTB14 SPAG5 LOXL2 TLN1 SLFN11 ATM TOP3A TP53BP1 | 4.45e-08 | 1249 | 196 | 34 | int:BRCA1 |
| Interaction | MECP2 interactions | KDM5B SETX SPTAN1 RPS11 ARID1A EZH2 CMAS NSRP1 HNRNPF HNRNPH1 MYEF2 HNRNPH2 NSD3 NRXN1 CLK1 SUPT6H HSPA5 DNMT1 GPD2 FLNC RANGAP1 SRSF7 DSP PUF60 CHD9 SKI ZCCHC4 SUGP2 MACF1 ATM CPSF3 TOP3A TP53BP1 | 2.89e-07 | 1287 | 196 | 33 | int:MECP2 |
| Interaction | STIP1 interactions | PSMA3 SPTAN1 RPS11 EZH2 HNRNPF HNRNPH1 STAT3 UBA1 CLK1 SUPT6H HSPA5 SLC12A6 FLNA RANGAP1 RARS1 SRSF7 PUF60 NUP98 TXNIP SUGP2 LOXL2 TLN1 HSD17B10 SLFN11 LRBA MAP2K2 CPSF3 IPO11 | 5.19e-07 | 1006 | 196 | 28 | int:STIP1 |
| Interaction | PSMD6 interactions | PSMA3 RO60 HNRNPF VPS33B UCHL5 TAX1BP1 MLH1 HSPA5 RMND5B FLNA OTUB1 ARHGEF12 EIF4E HSD17B10 TP53BP1 | 5.30e-07 | 317 | 196 | 15 | int:PSMD6 |
| Interaction | YWHAG interactions | HGF KDM5B SPTAN1 PAK4 NCAM2 EZH2 HNRNPH1 STAT3 UBA1 PIK3C2A CLK1 STARD9 PI4KB DCLK2 DNMT1 FLNA UACA DSP PUF60 INPP5F KIF7 ABLIM1 MACF1 PRKCE SLFN11 LRBA MAP2K2 CPSF3 DCLK1 EPB41L1 MAST3 | 1.37e-06 | 1248 | 196 | 31 | int:YWHAG |
| Interaction | PFN1 interactions | SPTAN1 EZH2 SRPRB PIK3C2A COG1 UCHL5 ZNF541 NCK2 ARHGEF12 INPP5F SPAG5 KIF7 ABLIM1 LOXL2 MACF1 ASB1 MAP2K2 TP53BP1 | 2.61e-06 | 509 | 196 | 18 | int:PFN1 |
| Interaction | SOX2 interactions | KDM5B SPTAN1 RPS11 KCTD21 ARID1A HNRNPF HNRNPH1 MYEF2 HNRNPH2 MFGE8 UBA1 UBR5 KDM2B PUM3 C5 TMED10 HSPA5 ENOX2 RMND5B FLNA RANGAP1 RARS1 DSP PUF60 NUP98 CHD9 KMT2D SUGP2 NOM1 MACF1 HSD17B10 SLFN11 EPHA7 | 2.63e-06 | 1422 | 196 | 33 | int:SOX2 |
| Interaction | EED interactions | SETX SPTAN1 RPS11 ARID1A EZH2 HNRNPF HNRNPH1 MYEF2 HNRNPH2 STAT3 UBA1 PIK3C2A SUPT6H KDM2B PUM3 HSPA5 DNMT1 FLNA RANGAP1 RARS1 SRSF7 DSP PUF60 OTUB1 NUP98 ABLIM1 GET4 XIRP2 NOM1 TLN1 MACF1 CPSF3 TP53BP1 | 3.71e-06 | 1445 | 196 | 33 | int:EED |
| Interaction | RICTOR interactions | RPS11 EZH2 SRPRB NSRP1 HNRNPH1 UBA1 PROZ UBR5 TMED10 HSPA5 GPD2 FLNA FLNC RARS1 DSP ABLIM1 SUGP2 NOM1 TLN1 GSDMA HSD17B10 MAP2K2 | 5.05e-06 | 759 | 196 | 22 | int:RICTOR |
| Interaction | MIR9-3 interactions | 5.28e-06 | 70 | 196 | 7 | int:MIR9-3 | |
| Interaction | HDAC5 interactions | KDM5B SPTAN1 RPS11 EZH2 HNRNPF MYEF2 HNRNPH2 PRKD3 UBA1 SUPT6H HSPA5 FLNA RARS1 DSP ARHGEF12 HSD17B10 | 5.38e-06 | 432 | 196 | 16 | int:HDAC5 |
| Interaction | BIRC3 interactions | PSMA3 SPTAN1 RPS11 RO60 SRPRB HNRNPF HNRNPH1 MFGE8 UBA1 SUPT6H STARD9 UCHL5 HSPA5 DNMT1 GPD2 FLNA RANGAP1 RARS1 SRSF7 DSP PUF60 OTUB1 SMC6 NUP98 CASP7 LAP3 GBA3 TLN1 EIF4E HSD17B10 CPSF3 | 5.38e-06 | 1334 | 196 | 31 | int:BIRC3 |
| Interaction | MIR29B2 interactions | 5.81e-06 | 71 | 196 | 7 | int:MIR29B2 | |
| Interaction | RB1CC1 interactions | EZH2 SRPRB HNRNPF STAT3 NSD3 ACSL1 MFGE8 TAX1BP1 TMED10 SRSF7 SKI TRIM5 SLFN11 TP53BP1 MAST3 | 6.21e-06 | 387 | 196 | 15 | int:RB1CC1 |
| Interaction | SNAI1 interactions | SPTAN1 RPS11 RO60 EZH2 CMAS HNRNPF HNRNPH1 HSPA5 ZNF541 DNMT1 RARS1 OTUB1 ZBTB14 NOM1 HSD17B10 ATM TOP3A IPO11 | 6.88e-06 | 546 | 196 | 18 | int:SNAI1 |
| Interaction | PABPC4 interactions | RPS11 RO60 EZH2 NSRP1 HNRNPH1 UBR5 HSPA5 RARS1 DSP PUF60 CHD9 SKI XIRP2 LOXL2 TLN1 EIF4E | 7.17e-06 | 442 | 196 | 16 | int:PABPC4 |
| Interaction | MIR20A interactions | 7.67e-06 | 74 | 196 | 7 | int:MIR20A | |
| Interaction | MIR19B1 interactions | 8.05e-06 | 104 | 196 | 8 | int:MIR19B1 | |
| Interaction | MIR429 interactions | 9.17e-06 | 76 | 196 | 7 | int:MIR429 | |
| Interaction | ACTN4 interactions | PSMA3 RO60 ARID1A EZH2 NSRP1 HNRNPH1 MYEF2 NRXN1 PIK3C2A UBR5 UCHL5 HSPA5 FLNA LOXL2 HASPIN | 9.21e-06 | 400 | 196 | 15 | int:ACTN4 |
| Interaction | FLNB interactions | EZH2 HNRNPH1 UBA1 NRXN1 MLH1 HSPA5 FLNA FLNC RARS1 DSP LOXL2 EIF4E SLFN11 | 9.28e-06 | 304 | 196 | 13 | int:FLNB |
| Interaction | MAPT interactions | SPTAN1 HNRNPF HNRNPH1 UBA1 DCLK2 HSPA5 RAB13 GPD2 FLNA FLNC RANGAP1 SRSF7 OTUB1 CASP7 GNPNAT1 ABLIM1 NUDT3 TLN1 PANK4 ELAVL4 PRKCE HSD17B10 ATM MAP2K2 ATP2B4 DCLK1 EPB41L1 | 1.20e-05 | 1119 | 196 | 27 | int:MAPT |
| Interaction | KCNA3 interactions | PAK4 RPS11 SRPRB HNRNPF HNRNPH1 STAT3 UBA1 HSPA5 NCK2 GPD2 RANGAP1 RARS1 DSP PUF60 EGLN1 ARHGEF12 CHD9 ABLIM1 TLN1 MACF1 HSD17B10 LRBA EPB41L1 | 1.38e-05 | 871 | 196 | 23 | int:KCNA3 |
| Interaction | PABPC1 interactions | SMG1 RO60 EZH2 NSRP1 HNRNPF HNRNPH1 UBA1 UBR5 HSPA5 FLNA FLNC RARS1 DSP PUF60 CHD9 SKI LOXL2 TLN1 EIF4E HSD17B10 | 1.68e-05 | 699 | 196 | 20 | int:PABPC1 |
| Interaction | MAP4 interactions | RO60 EZH2 HNRNPF NRXN1 UCHL5 HSPA5 FLNA RARS1 DSP OTUB1 ZBTB14 SPAG5 LOXL2 | 1.82e-05 | 324 | 196 | 13 | int:MAP4 |
| Interaction | FBXW7 interactions | PSMA3 RPS11 EZH2 ITGAV NSRP1 HNRNPF HNRNPH2 STAT3 SUPT6H PI4KB MED13 DNMT1 FLNA RARS1 SRSF7 UACA PUF60 OTUB1 TXNIP KMT2D SUGP2 NOM1 RNF146 MACF1 PRKCE CPSF3 CWF19L1 TOP3A | 1.89e-05 | 1215 | 196 | 28 | int:FBXW7 |
| Interaction | MIR9-1 interactions | 1.92e-05 | 85 | 196 | 7 | int:MIR9-1 | |
| Interaction | MIR20B interactions | 2.08e-05 | 86 | 196 | 7 | int:MIR20B | |
| Interaction | U2AF2 interactions | SPTAN1 RO60 EZH2 HNRNPF HNRNPH1 SCAF1 UBA1 UBR5 CLK1 UCHL5 HSPA5 FLNA RANGAP1 SRSF7 PUF60 LAP3 TLN1 CPSF3 TP53BP1 | 2.10e-05 | 651 | 196 | 19 | int:U2AF2 |
| Interaction | MIR141 interactions | 2.41e-05 | 88 | 196 | 7 | int:MIR141 | |
| Interaction | MIR29C interactions | 2.60e-05 | 89 | 196 | 7 | int:MIR29C | |
| Interaction | MIR221 interactions | 2.79e-05 | 90 | 196 | 7 | int:MIR221 | |
| Interaction | MIR92A2 interactions | 2.79e-05 | 90 | 196 | 7 | int:MIR92A2 | |
| Interaction | ERP29 interactions | 2.92e-05 | 124 | 196 | 8 | int:ERP29 | |
| Interaction | CEBPA interactions | SETX PSMA3 SPTAN1 MBNL1 ARID1A ACSL1 UBA1 UBR5 PUM3 TMED10 HSPA5 DNMT1 FLNA RARS1 SRSF7 PUF60 NELFA OTUB1 CHD9 KMT2D GET4 SUGP2 TLN1 EIF4E MACF1 SLFN11 TP53BP1 IPO11 | 2.93e-05 | 1245 | 196 | 28 | int:CEBPA |
| Interaction | NAA40 interactions | PAK4 RPS11 NSRP1 HNRNPF HNRNPH1 STAT3 UBA1 MLH1 DNMT1 FLNA RANGAP1 DSP PUF60 EGLN1 NUP98 SPAG5 ABLIM1 SUGP2 TLN1 MACF1 SLFN11 LRBA CPSF3 TP53BP1 | 2.93e-05 | 978 | 196 | 24 | int:NAA40 |
| Interaction | KIF20A interactions | SETX SPTAN1 RPS11 EZH2 HNRNPF HNRNPH2 NSD3 PIK3C2A UBR5 COG1 SUPT6H PUM3 FLNA FLNC SRSF7 UACA DSP PUF60 NUP98 RHOT2 TRIM5 GBA3 ABLIM1 SUGP2 MACF1 | 3.35e-05 | 1052 | 196 | 25 | int:KIF20A |
| Interaction | KCTD13 interactions | SPTAN1 RPS11 NCAM2 ARID1A CMAS HNRNPF HNRNPH1 MYEF2 UBA1 DCLK2 HSPA5 NCK2 GPD2 CACNA1A SLC12A6 FLNA FLNC SRSF7 DSP ARHGEF12 ABLIM1 SUGP2 TLN1 EIF4E MACF1 PRKCE ABLIM2 ATP2B4 DCLK1 EPB41L1 | 3.37e-05 | 1394 | 196 | 30 | int:KCTD13 |
| Interaction | FSCN1 interactions | PSMA3 RPS11 RO60 EZH2 TMED10 HSPA5 CACNA1A FLNA LOXL2 PRKCE MAP2K2 | 3.66e-05 | 251 | 196 | 11 | int:FSCN1 |
| Interaction | AR interactions | KDM5B RPS11 ARID1A EZH2 HNRNPF HNRNPH1 MYEF2 HNRNPH2 STAT3 UBR5 UCHL5 TAX1BP1 KDM2B HSPA5 MED13 FLNA DSP PUF60 NELFA OTUB1 CASP7 SKI KMT2D SUGP2 | 3.67e-05 | 992 | 196 | 24 | int:AR |
| Interaction | MIR19B2 interactions | 3.70e-05 | 94 | 196 | 7 | int:MIR19B2 | |
| Interaction | TRIM28 interactions | SPTAN1 RPS11 KCTD21 EZH2 CMAS HNRNPF HNRNPH1 HNRNPH2 STAT3 VPS33B PIK3C2A UBR5 PUM3 DNMT1 RMND5B RANGAP1 OTUB1 APAF1 RHOT2 SKI LAP3 TXNIP ZCCHC4 SUGP2 ZNF420 HSD17B10 ATM LRBA TOP3A TP53BP1 MAST3 | 3.79e-05 | 1474 | 196 | 31 | int:TRIM28 |
| Interaction | CYLD interactions | SETX PSMA3 SPTAN1 RPS11 HNRNPF HNRNPH1 MYEF2 HNRNPH2 STAT3 VPS33B HSPA5 FLNA FLNC RANGAP1 RARS1 UACA DSP ARHGEF12 ABLIM1 TLN1 EIF4E GSDMA | 3.99e-05 | 868 | 196 | 22 | int:CYLD |
| Interaction | SIRT7 interactions | SPTAN1 ARID1A HNRNPF MYEF2 UBR5 SUPT6H PUM3 DNMT1 FLNA FLNC RANGAP1 DSP PUF60 NUP98 SUGP2 TLN1 MACF1 ATM CPSF3 TP53BP1 | 4.06e-05 | 744 | 196 | 20 | int:SIRT7 |
| Interaction | AGR2 interactions | PSMA3 SPTAN1 RPS11 HNRNPF HNRNPH1 MYEF2 MLH1 CACNA1G HSPA5 GPD2 FLNA FLNC RARS1 DSP PUF60 GNPNAT1 MUC5B SPAG5 GET4 TLN1 MACF1 HSD17B10 LRBA | 4.12e-05 | 934 | 196 | 23 | int:AGR2 |
| Interaction | TRPV1 interactions | 4.32e-05 | 131 | 196 | 8 | int:TRPV1 | |
| Interaction | ITGB3 interactions | 4.44e-05 | 170 | 196 | 9 | int:ITGB3 | |
| Interaction | MIR21 interactions | 4.54e-05 | 97 | 196 | 7 | int:MIR21 | |
| Interaction | MIR363 interactions | 4.54e-05 | 97 | 196 | 7 | int:MIR363 | |
| Interaction | SLX4 interactions | PSMA3 HNRNPF HNRNPH1 UBA1 UBR5 SUPT6H MLH1 HSPA5 FLNA RANGAP1 RARS1 DSP NELFA CHD9 SUGP2 GSDMA TP53BP1 | 4.64e-05 | 572 | 196 | 17 | int:SLX4 |
| Interaction | VCL interactions | SPTAN1 PAK4 EZH2 HSPA5 ENOX2 GNPNAT1 LAP3 LOXL2 TLN1 MACF1 HSD17B10 SLFN11 | 4.65e-05 | 305 | 196 | 12 | int:VCL |
| Interaction | IGHMBP2 interactions | 4.66e-05 | 41 | 196 | 5 | int:IGHMBP2 | |
| Interaction | EEF1G interactions | PSMA3 EZH2 SCAF1 UBR5 UCHL5 MLH1 HSPA5 NCK2 FLNC RANGAP1 SRSF7 CHD9 GET4 NUDT3 HSD17B10 | 5.02e-05 | 463 | 196 | 15 | int:EEF1G |
| Interaction | KAT5 interactions | SETX SPTAN1 HNRNPF STAT3 TAX1BP1 KDM2B DNMT1 FLNA RANGAP1 ZBTB14 GET4 PRKCE ATM | 5.13e-05 | 358 | 196 | 13 | int:KAT5 |
| Interaction | MIR128-2 interactions | 5.17e-05 | 99 | 196 | 7 | int:MIR128-2 | |
| Interaction | MIR19A interactions | 5.52e-05 | 100 | 196 | 7 | int:MIR19A | |
| Interaction | C8A interactions | 5.53e-05 | 22 | 196 | 4 | int:C8A | |
| Interaction | HSPA6 interactions | RO60 EZH2 HNRNPH1 UBA1 SUPT6H HSPA5 FLNA DSP DUSP6 OTUB1 SKI TLN1 | 5.61e-05 | 311 | 196 | 12 | int:HSPA6 |
| Interaction | MAU2 interactions | 5.65e-05 | 136 | 196 | 8 | int:MAU2 | |
| Interaction | MIRLET7D interactions | 5.88e-05 | 101 | 196 | 7 | int:MIRLET7D | |
| Interaction | MIR25 interactions | 5.88e-05 | 101 | 196 | 7 | int:MIR25 | |
| Interaction | PSMD14 interactions | SETX PSMA3 EZH2 HNRNPH1 HNRNPH2 UBA1 SUPT6H UCHL5 HSPA5 FLNA RARS1 DSP SPAG5 GET4 HSD17B10 TP53BP1 | 6.08e-05 | 527 | 196 | 16 | int:PSMD14 |
| Interaction | WWTR1 interactions | SPTAN1 ARID1A STAT3 UBA1 HSPA5 DNMT1 RANGAP1 PUF60 ABLIM1 KMT2D SUGP2 TLN1 LRBA TP53BP1 | 6.98e-05 | 422 | 196 | 14 | int:WWTR1 |
| Interaction | WDR5 interactions | SETD1B PSMA3 SPTAN1 RPS11 RO60 SRPRB HNRNPF HNRNPH1 HNRNPH2 UBR5 KDM2B C9 HSPA5 DNMT1 FLNA RARS1 SRSF7 DSP PUF60 NUP98 KMT2D TLN1 EIF4E MACF1 MAP2K2 | 7.00e-05 | 1101 | 196 | 25 | int:WDR5 |
| Interaction | UBE2M interactions | PSMA3 SPTAN1 RPS11 EZH2 SRPRB HNRNPF HNRNPH1 PRKD3 UBA1 UCHL5 HSPA5 FLNA RANGAP1 RARS1 UACA PUF60 LAP3 HSD17B10 | 7.01e-05 | 651 | 196 | 18 | int:UBE2M |
| Interaction | OBSL1 interactions | EZH2 HNRNPF HNRNPH1 MYEF2 HNRNPH2 SCAF1 UBA1 SEMA5B SUPT6H PUM3 HSPA5 FLNA FLNC RANGAP1 SRSF7 DSP PUF60 NUP98 SUGP2 TLN1 MACF1 HSD17B10 | 7.04e-05 | 902 | 196 | 22 | int:OBSL1 |
| Interaction | COPS5 interactions | SPTAN1 RPS11 RO60 HNRNPF HNRNPH1 HNRNPH2 STAT3 TINAGL1 UBA1 PIK3C2A HSPA5 AMPD1 SRSF7 DSP PUF60 RHOT2 TXNIP GUCY1A1 HSD17B10 ATM LRBA MAP2K2 CPSF3 EPB41L1 TP53BP1 | 7.10e-05 | 1102 | 196 | 25 | int:COPS5 |
| Interaction | MIR29B1 interactions | 7.77e-05 | 73 | 196 | 6 | int:MIR29B1 | |
| Interaction | CUL7 interactions | NSRP1 HNRNPF HNRNPH1 MYEF2 HNRNPH2 UBA1 SUPT6H HSPA5 PLXNB3 GPD2 FLNA RANGAP1 SRSF7 DSP PUF60 NUP98 TLN1 MACF1 HSD17B10 MAP2K2 EPHA7 | 7.97e-05 | 845 | 196 | 21 | int:CUL7 |
| Interaction | MIRLET7E interactions | 8.00e-05 | 106 | 196 | 7 | int:MIRLET7E | |
| Interaction | PHLDB2 interactions | 8.04e-05 | 143 | 196 | 8 | int:PHLDB2 | |
| Interaction | FBXO43 interactions | 8.38e-05 | 74 | 196 | 6 | int:FBXO43 | |
| Interaction | DHX9 interactions | SPTAN1 MBNL1 RPS11 RO60 EZH2 NSRP1 HNRNPF HNRNPH1 NSD3 HSPA5 RARS1 SRSF7 PUF60 RHOT2 SUGP2 LOXL2 EIF4E SLFN11 | 8.67e-05 | 662 | 196 | 18 | int:DHX9 |
| Interaction | YWHAE interactions | KDM5B SPTAN1 PAK4 NCAM2 RO60 EZH2 HNRNPH1 UBA1 PIK3C2A PI4KB DCLK2 DNMT1 FLNA SRSF7 INPP5F ABLIM1 LOXL2 MACF1 PRKCE SLFN11 LRBA MAP2K2 ATP2B4 CWF19L1 DCLK1 EPB41L1 MAST3 | 8.85e-05 | 1256 | 196 | 27 | int:YWHAE |
| Interaction | MIR15A interactions | 9.04e-05 | 75 | 196 | 6 | int:MIR15A | |
| Interaction | MAP3K13 interactions | 9.10e-05 | 47 | 196 | 5 | int:MAP3K13 | |
| Interaction | MIA3 interactions | SLC25A46 SRPRB VPS33B TAX1BP1 HSPA5 NCK2 MICOS10 CACNA1A RHOT2 HSD17B14 | 9.19e-05 | 231 | 196 | 10 | int:MIA3 |
| Interaction | GATA3 interactions | 9.27e-05 | 187 | 196 | 9 | int:GATA3 | |
| Interaction | MIR16-1 interactions | 9.74e-05 | 76 | 196 | 6 | int:MIR16-1 | |
| Interaction | MIR34B interactions | 1.01e-04 | 110 | 196 | 7 | int:MIR34B | |
| Interaction | MIR200A interactions | 1.05e-04 | 77 | 196 | 6 | int:MIR200A | |
| Interaction | CASP9 interactions | 1.05e-04 | 77 | 196 | 6 | int:CASP9 | |
| Interaction | PHLPP1 interactions | SPTAN1 RPS11 ARID1A STAT3 MYPN FLNA RANGAP1 RARS1 DSP NUP98 SPAG5 TLN1 | 1.07e-04 | 333 | 196 | 12 | int:PHLPP1 |
| Interaction | PTEN interactions | SETX SPTAN1 RPS11 ARID1A EZH2 CMAS HNRNPH2 UBA1 RAB13 FLNA RANGAP1 SRSF7 DSP NUP98 SUGP2 RNF146 EIF4E HSD17B10 ATM EPB41L1 TP53BP1 MAST3 | 1.08e-04 | 929 | 196 | 22 | int:PTEN |
| Interaction | PXN interactions | PAK4 ITGAV PIK3C2A HSPA5 NCK2 ARHGEF12 KIF7 ABLIM1 RNF146 TLN1 MACF1 MAP2K2 | 1.10e-04 | 334 | 196 | 12 | int:PXN |
| Interaction | FAF1 interactions | RO60 SRPRB HNRNPF HNRNPH1 HSPA5 PUF60 NLRX1 NUP98 GET4 IGF2 TLN1 HSD17B10 | 1.10e-04 | 334 | 196 | 12 | int:FAF1 |
| Interaction | MIR92A1 interactions | 1.13e-04 | 78 | 196 | 6 | int:MIR92A1 | |
| Interaction | MIR451A interactions | 1.13e-04 | 78 | 196 | 6 | int:MIR451A | |
| Interaction | PINK1 interactions | SPTAN1 HNRNPH1 HNRNPH2 STAT3 ACSL1 UBA1 HSPA5 FLNA FLNC RARS1 SRSF7 DSP NLRX1 RHOT2 SUGP2 TLN1 GSDMA HSD17B10 | 1.19e-04 | 679 | 196 | 18 | int:PINK1 |
| Interaction | MIR1-2 interactions | 1.21e-04 | 79 | 196 | 6 | int:MIR1-2 | |
| Interaction | PARP16 interactions | 1.23e-04 | 50 | 196 | 5 | int:PARP16 | |
| Interaction | MIRLET7I interactions | 1.26e-04 | 114 | 196 | 7 | int:MIRLET7I | |
| Interaction | MIR143 interactions | 1.30e-04 | 80 | 196 | 6 | int:MIR143 | |
| Interaction | MIRLET7G interactions | 1.49e-04 | 117 | 196 | 7 | int:MIRLET7G | |
| Interaction | MIR106A interactions | 1.59e-04 | 83 | 196 | 6 | int:MIR106A | |
| Interaction | MIR31 interactions | 1.70e-04 | 84 | 196 | 6 | int:MIR31 | |
| Interaction | MIR7-2 interactions | 1.70e-04 | 84 | 196 | 6 | int:MIR7-2 | |
| Interaction | MBNL1 interactions | MBNL1 HNRNPF HNRNPH1 HNRNPH2 STAT3 NLRX1 MBNL2 GSDMA MBNL3 TP53BP1 | 1.70e-04 | 249 | 196 | 10 | int:MBNL1 |
| GeneFamily | RNA binding motif containing | SETD1B HNRNPF HNRNPH1 MYEF2 HNRNPH2 ENOX2 SRSF7 PUF60 ELAVL4 | 5.92e-05 | 213 | 146 | 9 | 725 |
| GeneFamily | Doublecortin superfamily | 5.94e-05 | 10 | 146 | 3 | 1369 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.57e-04 | 34 | 146 | 4 | 487 | |
| GeneFamily | PHD finger proteins | 8.12e-04 | 90 | 146 | 5 | 88 | |
| GeneFamily | Zinc fingers GRF-type|Topoisomerases | 1.32e-03 | 7 | 146 | 2 | 135 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.76e-03 | 8 | 146 | 2 | 939 | |
| GeneFamily | ATPases Ca2+ transporting | 2.25e-03 | 9 | 146 | 2 | 1209 | |
| GeneFamily | Zinc fingers CCCH-type | 2.79e-03 | 35 | 146 | 3 | 73 | |
| GeneFamily | Complement system|Sushi domain containing | 3.03e-03 | 36 | 146 | 3 | 492 | |
| GeneFamily | Zinc fingers CXXC-type | 4.05e-03 | 12 | 146 | 2 | 136 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BDP1 SMG1 SETX SPTAN1 MBNL1 RPS11 RO60 ARID1A HNRNPH1 STAT3 PRKD3 UBR5 CLK1 MED13 DNMT1 FLNA SRSF7 DUSP6 NUP98 OAS2 SKI TXNIP KMT2D TLN1 MACF1 SLFN11 ATM LRBA ATP2B4 MAST3 SP140 | 2.95e-07 | 1492 | 198 | 31 | M40023 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SLC25A46 SMG1 SETX MBNL1 RO60 CMAS ITGAV SRPRB UBR5 CLK1 TMED10 HSPA5 NCK2 RMND5B EGLN1 DUSP6 APAF1 NUP98 CHD9 E2F5 SLC7A1 NUDT3 MBNL2 MACF1 ATM LRBA TOP3A | 5.22e-07 | 1215 | 198 | 27 | M41122 |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP | SMG1 SETX MBNL1 RO60 SRPRB CD163 PIK3C2A TAX1BP1 ENOX2 DUSP6 APAF1 TRIM5 MCTP1 MBNL2 RNF146 ATM | 7.78e-07 | 477 | 198 | 16 | M40930 |
| Coexpression | GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP | 2.27e-05 | 200 | 198 | 9 | M8090 | |
| Coexpression | GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_DN | 2.27e-05 | 200 | 198 | 9 | M7276 | |
| Coexpression | GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN | 2.27e-05 | 200 | 198 | 9 | M7502 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP | 4.84e-05 | 27 | 198 | 4 | M1245 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_UP | 5.37e-05 | 173 | 198 | 8 | M2385 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | TAX1BP1 DNMT1 GPD2 FLNC RANGAP1 CASP7 CHD9 SKI ZBTB14 ABLIM1 NUDT3 GSG1L EPHA7 | 6.03e-05 | 467 | 198 | 13 | M1347 |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED | 6.47e-05 | 29 | 198 | 4 | M47987 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | KDM5B PSMA3 MBNL1 ARID1A ITGAV HNRNPF STAT3 CLK1 TAX1BP1 MLH1 KDM2B TMED10 GPD2 RMND5B EGLN1 DUSP6 ARHGEF12 TRIM5 TXNIP DENND6A MRNIP ATM MAP2K2 | 6.68e-05 | 1239 | 198 | 23 | M1743 |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | SMG1 MBNL1 ARID1A ITGAV HNRNPH1 TINAGL1 TAX1BP1 HSPA5 DSE RANGAP1 DSP DUSP6 CHD9 SLC7A1 ABLIM1 MBNL2 TLN1 EIF4E | 7.75e-05 | 843 | 198 | 18 | M2356 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | TAX1BP1 DNMT1 GPD2 FLNC RANGAP1 CASP7 CHD9 SKI ZBTB14 ABLIM1 NUDT3 GSG1L EPHA7 | 8.64e-05 | 484 | 198 | 13 | MM999 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | RO60 MED13 NCK2 GPD2 SLC12A6 UACA DSP DUSP6 E2F5 TRIM5 TXNIP DENND6A MBNL2 GUCY1A1 LOXL2 MACF1 LRBA MBNL3 | 9.13e-05 | 854 | 198 | 18 | M1533 |
| Coexpression | KATSANOU_ELAVL1_TARGETS_UP | 9.61e-05 | 188 | 198 | 8 | MM1071 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | KDM5B PSMA3 MBNL1 ARID1A ITGAV HNRNPF STAT3 CLK1 TAX1BP1 MLH1 KDM2B TMED10 GPD2 RMND5B EGLN1 DUSP6 ARHGEF12 TRIM5 TXNIP DENND6A MRNIP ATM MAP2K2 | 1.05e-04 | 1277 | 198 | 23 | MM1032 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HOPC | CADM4 NCAM2 ITGAV NRXN1 CACNA1G DCLK2 WSCD1 IGF1 MCTP1 ATP2B4 TOP3A | 1.15e-04 | 366 | 198 | 11 | M39052 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | CADM4 ITGAV SVEP1 STAT3 MFGE8 RAB13 NCK2 FLNA UACA DSP ARHGEF12 TXNIP GUCY1A1 LOXL2 TLN1 DCLK3 EPB41L1 | 1.21e-04 | 795 | 198 | 17 | M39050 |
| Coexpression | GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN | 1.42e-04 | 199 | 198 | 8 | M7779 | |
| Coexpression | GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN | 1.42e-04 | 199 | 198 | 8 | M7998 | |
| Coexpression | GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN | 1.42e-04 | 199 | 198 | 8 | M3175 | |
| Coexpression | GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_UP | 1.47e-04 | 200 | 198 | 8 | M4663 | |
| Coexpression | GSE27786_LIN_NEG_VS_MONO_MAC_UP | 1.47e-04 | 200 | 198 | 8 | M4796 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP | 1.47e-04 | 200 | 198 | 8 | M3470 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_DN | 1.47e-04 | 200 | 198 | 8 | M3640 | |
| Coexpression | GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_DN | 1.47e-04 | 200 | 198 | 8 | M7750 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_UP | 1.47e-04 | 200 | 198 | 8 | M5209 | |
| Coexpression | GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_DN | 1.47e-04 | 200 | 198 | 8 | M7801 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | RO60 MED13 NCK2 GPD2 SLC12A6 UACA DSP DUSP6 E2F5 TRIM5 TXNIP DENND6A MBNL2 GUCY1A1 LOXL2 MACF1 LRBA MBNL3 | 1.48e-04 | 888 | 198 | 18 | MM1018 |
| Coexpression | FISCHER_DREAM_TARGETS | EZH2 HNRNPF HNRNPH1 UCHL5 DNMT1 GPD2 RANGAP1 SRSF7 UACA SMC6 NUP98 ZBTB14 SPAG5 EIF4E HASPIN SLFN11 CWF19L1 TOP3A IPO11 | 1.48e-04 | 969 | 198 | 19 | M149 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | KDM5B PSMA3 ZKSCAN7 RO60 CMAS HNRNPF HNRNPH2 STAT3 PRKD3 ACSL1 VPS33B UCHL5 TAX1BP1 MLH1 MED13 SLC12A6 FLNA RANGAP1 NELFA NUP98 NUDT3 MBNL2 EIF4E MAP2K2 | 1.54e-04 | 1399 | 198 | 24 | M535 |
| Coexpression | IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN | 1.65e-04 | 107 | 198 | 6 | M4913 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | HSPA5 RAB13 DSE FLNA UACA TXNIP IGF2 GUCY1A1 LOXL2 TLN1 EPHA7 | 1.79e-04 | 385 | 198 | 11 | M39264 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | SLC25A46 MBNL1 RO60 MYEF2 HNRNPH2 PIK3C2A UCHL5 TAX1BP1 PUM3 RAB13 GNPNAT1 MBNL2 DCLK1 | 1.85e-04 | 523 | 198 | 13 | M12707 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 1.98e-04 | 157 | 198 | 7 | M7733 | |
| Coexpression | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN | 2.02e-04 | 266 | 198 | 9 | M1845 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | SLC25A46 MBNL1 RO60 MYEF2 HNRNPH2 PIK3C2A UCHL5 TAX1BP1 PUM3 RAB13 GNPNAT1 MBNL2 DCLK1 | 2.27e-04 | 534 | 198 | 13 | MM1054 |
| Coexpression | HSIAO_HOUSEKEEPING_GENES | RPS11 HNRNPF STAT3 CES2 UBA1 TAX1BP1 MLH1 TMED10 FLNA TXNIP ABLIM1 | 2.32e-04 | 397 | 198 | 11 | M11197 |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | HGF TINAGL1 MFGE8 SEMA5B UACA STEAP4 THSD7B GUCY1A1 DCLK3 GPR176 DCLK1 | 8.39e-10 | 187 | 198 | 11 | b8f88599e22b9b345c7ec3bbecd87a8b2a033f9f |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | SETX SPTAN1 UACA ARHGEF12 OAS2 LAP3 TXNIP MCTP1 GUCY1A1 MACF1 PRKCE | 1.71e-09 | 200 | 198 | 11 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 9.12e-09 | 181 | 198 | 10 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | MYPN PPM1L MYO18B FLNC ARHGEF12 FHOD3 ABLIM1 XIRP2 ATP2B4 MYBPC3 | 1.38e-08 | 189 | 198 | 10 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MBNL1 HNRNPF HNRNPH1 HNRNPH2 STAT3 HSPA5 MED13 ARHGEF12 MBNL2 LOXL2 | 1.95e-08 | 196 | 198 | 10 | 151f1a29a91f8b234e9b6ed062666357a2f69128 |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | SETX SPTAN1 UACA ARHGEF12 CASP7 OAS2 LAP3 TXNIP MCTP1 GUCY1A1 | 2.36e-08 | 200 | 198 | 10 | 89821a264e872ed53e08e9d3609d5cc5c314503e |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.91e-07 | 190 | 198 | 9 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | PND07|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.08e-07 | 192 | 198 | 9 | 8171a60df481195c39a7f740effcae8e4deb6ca7 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.18e-07 | 193 | 198 | 9 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-07 | 194 | 198 | 9 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.59e-07 | 197 | 198 | 9 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-07 | 199 | 198 | 9 | 9e32644b93fb1c4946dbe388fd5c357304d14e36 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 2.94e-07 | 200 | 198 | 9 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.94e-07 | 200 | 198 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 6.76e-07 | 162 | 198 | 8 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 9.72e-07 | 170 | 198 | 8 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 198 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 198 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 198 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.91e-06 | 186 | 198 | 8 | 1e3ab663e4756975db6d802b2c6c054a94a79393 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-06 | 189 | 198 | 8 | 9e1a51997ef9b6999d9b40cf0a55e561e3b4a84c | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-06 | 190 | 198 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-06 | 191 | 198 | 8 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-06 | 191 | 198 | 8 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-06 | 191 | 198 | 8 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-06 | 191 | 198 | 8 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.42e-06 | 192 | 198 | 8 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.42e-06 | 192 | 198 | 8 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 192 | 198 | 8 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 192 | 198 | 8 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.61e-06 | 194 | 198 | 8 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.71e-06 | 195 | 198 | 8 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-06 | 196 | 198 | 8 | a582130862bee76c0385156a333bfdfc75cf218b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-06 | 196 | 198 | 8 | fba52a4b82086dbae9a55038bf44c4539be926f5 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-06 | 196 | 198 | 8 | 5ed7f063fc4ba213fe15256caf77f59c9e476290 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.93e-06 | 197 | 198 | 8 | 452be45f4aac8459dd860493171f5f715368d663 | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 3.04e-06 | 198 | 198 | 8 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | COVID_vent-Lymphocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.04e-06 | 198 | 198 | 8 | ee80f647317377081b4bd194ee2801f556b3a53b | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 3.04e-06 | 198 | 198 | 8 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.04e-06 | 198 | 198 | 8 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.15e-06 | 199 | 198 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 198 | 8 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 198 | 8 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 198 | 8 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.27e-06 | 200 | 198 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 198 | 8 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 198 | 8 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 198 | 8 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 198 | 8 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 198 | 8 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 198 | 8 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 7.29e-06 | 159 | 198 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.57e-06 | 163 | 198 | 7 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.57e-06 | 163 | 198 | 7 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-05 | 169 | 198 | 7 | 42a9b8c77d2a4d68b01e4db38f8a1af53c9c814f | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-05 | 169 | 198 | 7 | 88aa2246ede582c2e11de63228d76f520889ecb3 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-05 | 169 | 198 | 7 | a6a5b00912b653fad2ca7f096deaf35c9ef85e5b | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.13e-05 | 170 | 198 | 7 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.17e-05 | 171 | 198 | 7 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 174 | 198 | 7 | 197686570cec6d96a92e77e6409325d3bfe6f991 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 174 | 198 | 7 | 2eee7b5471672b439f95eba11494c2adf8cb7006 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.41e-05 | 176 | 198 | 7 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 177 | 198 | 7 | 692cd03bf0958ebeec34d41bfe87713a768e9a8e | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 177 | 198 | 7 | c08583ea68bbeb6b5de852a46b0c0f04792dae55 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-05 | 180 | 198 | 7 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 181 | 198 | 7 | 395cf5aa2d89b05328ab516b8c89401020b6d830 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 181 | 198 | 7 | 429df38438d5a7ff490c9ede34b69e2970c7ded2 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 1.69e-05 | 181 | 198 | 7 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 182 | 198 | 7 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.75e-05 | 182 | 198 | 7 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.82e-05 | 183 | 198 | 7 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.82e-05 | 183 | 198 | 7 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 184 | 198 | 7 | 9c20b50f8d6ac689d41d5440c835f9db8d04758b | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.88e-05 | 184 | 198 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 184 | 198 | 7 | 31dbe6119a3bcd266ae5e9b340c853d9ff680dce | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.95e-05 | 185 | 198 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-05 | 185 | 198 | 7 | 35d39a1d04c871edcfb749653538dc5fd0054281 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 186 | 198 | 7 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 186 | 198 | 7 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 187 | 198 | 7 | a12f383b02b07af32cc53a154685df8dba8fbd3f | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 187 | 198 | 7 | c40c152fa14e6afc9188549534b64ccbaded56b3 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.09e-05 | 187 | 198 | 7 | 6820bfbe552ea5e62cfe699687b051a17d9fda61 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.09e-05 | 187 | 198 | 7 | 43ef900b76f3c38bd8ce9858201124130c743d56 | |
| ToppCell | facs-Heart-Unknown-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 187 | 198 | 7 | c004567767b89f3d89f5c7b28d952f3445957e1e | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 187 | 198 | 7 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.09e-05 | 187 | 198 | 7 | 6e5c38425b6b1d4774f8dcea7e146f1eab785c3e | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.09e-05 | 187 | 198 | 7 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 187 | 198 | 7 | 0ffb988e0da2c7205c3515eca8e9851739bff5c5 | |
| ToppCell | facs-Heart-Unknown|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 187 | 198 | 7 | 362e56426a568423a81e8a30e3ecf99b76135843 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.16e-05 | 188 | 198 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 188 | 198 | 7 | 90dc0e15798d0b984518ad58c7e416e30aff687a | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 188 | 198 | 7 | f63dfd076ced81013918363282ae25cbbd8948ae | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 188 | 198 | 7 | 0554d542149cef654ff1e5e32dfbffd8990b52bd | |
| ToppCell | facs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 189 | 198 | 7 | a08b2d0fa35ffa510050ecffdc68e1b79bbe1632 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 189 | 198 | 7 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | facs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 189 | 198 | 7 | efa913d9c16fc32166b484d92b6449e8a0c59e03 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 189 | 198 | 7 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.31e-05 | 190 | 198 | 7 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 2.31e-05 | 190 | 198 | 7 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.31e-05 | 190 | 198 | 7 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| Computational | Actin cytoskeleton binding. | 2.39e-05 | 30 | 127 | 5 | MODULE_524 | |
| Drug | phloretin | 2.25e-06 | 131 | 198 | 9 | CID000004788 | |
| Drug | lavendustin A | HGF PRKD3 PIK3C2A CACNA1G CACNA1A IGF1 EIF4E PRKCE LRBA MAP2K2 | 2.64e-06 | 171 | 198 | 10 | CID000003894 |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; PC3; HT_HG-U133A | SPTAN1 ARID1A ASB8 WSCD1 ARHGEF12 STEAP4 CPT2 TXNIP ZCCHC4 ATM | 7.75e-06 | 193 | 198 | 10 | 5839_DN |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | SUPT6H ATP2C2 ENOX2 RANGAP1 OTUB1 ARHGEF12 STEAP4 CPT2 ATM MAST3 | 8.87e-06 | 196 | 198 | 10 | 5827_DN |
| Drug | Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; HL60; HT_HG-U133A | 9.28e-06 | 197 | 198 | 10 | 2343_DN | |
| Drug | Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 9.70e-06 | 198 | 198 | 10 | 6479_DN | |
| Drug | Tinidazole [19387-91-8]; Up 200; 16.2uM; MCF7; HT_HG-U133A | ARID1A PI4KB TAX1BP1 ATP2C2 GPD2 WSCD1 RHOT2 SLC7A1 HSD17B14 TOP3A | 1.01e-05 | 199 | 198 | 10 | 3430_UP |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A | HGF SETD1B SVEP1 CD163 ARHGEF12 STEAP4 TLN1 ATP2B4 MAST3 MYBPC3 | 1.01e-05 | 199 | 198 | 10 | 3205_UP |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Down 200; 21uM; MCF7; HT_HG-U133A | 1.01e-05 | 199 | 198 | 10 | 7184_DN | |
| Drug | pentabromodiphenyl ether | PSMA3 ARID1A HNRNPH1 MYEF2 HNRNPH2 NSD3 CLK1 CACNA1G TMED10 ZNF709 HSPA5 MED13 GPD2 FLNC AMPD1 SRSF7 STEAP4 LAP3 TXNIP SLC7A1 IGF1 MBNL2 GUCY1A1 TLN1 EIF4E PRKCE DCLK1 | 1.51e-05 | 1266 | 198 | 27 | ctd:C086401 |
| Drug | 4-epidoxorubicin | PSMA3 MBNL1 F11 POLR1H STAT3 PRKD3 MFGE8 PIK3C2A MLH1 DNMT1 APAF1 ARHGEF12 CASP7 TXNIP MBNL2 PRKCE ATM MAP2K2 TOP3A MBNL3 | 1.92e-05 | 788 | 198 | 20 | CID000001690 |
| Drug | pp175 | 2.21e-05 | 7 | 198 | 3 | CID000006543 | |
| Drug | 17-AAG; Up 200; 1uM; HL60; HT_HG-U133A | 2.25e-05 | 174 | 198 | 9 | 6177_UP | |
| Drug | 9,11-octadecadienoic acid | 3.52e-05 | 142 | 198 | 8 | CID000074607 | |
| Drug | glycerol | HK3 SPTAN1 NCAM2 F11 PRKD3 PIK3C2A SUPT6H TRAPPC6B MLH1 DNMT1 GPD2 NLRX1 CPT2 GBA3 NOM1 LRP5 PRKCE HSD17B10 GPR176 SP140 | 3.92e-05 | 829 | 198 | 20 | CID000000753 |
| Drug | AC1Q6AQ7 | 4.14e-05 | 188 | 198 | 9 | CID000005515 | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 4.14e-05 | 188 | 198 | 9 | 4845_DN | |
| Drug | Go6976 | 4.49e-05 | 190 | 198 | 9 | CID000003501 | |
| Drug | Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; HL60; HT_HG-U133A | 4.68e-05 | 191 | 198 | 9 | 2368_UP | |
| Drug | 2,5-dimethylcelecoxib | 5.24e-05 | 9 | 198 | 3 | ctd:C506698 | |
| Drug | Gly-pro-glu | 5.24e-05 | 9 | 198 | 3 | CID003080768 | |
| Drug | Chlorthalidone [77-36-1]; Down 200; 11.8uM; HL60; HG-U133A | 5.28e-05 | 194 | 198 | 9 | 1581_DN | |
| Drug | 2-amino-3-phosphonopropionic acid | 5.29e-05 | 76 | 198 | 6 | CID000003857 | |
| Drug | 4-phenylbutyric acid | 5.46e-05 | 151 | 198 | 8 | ctd:C075773 | |
| Drug | Felodipine [72509-76-3]; Up 200; 10.4uM; PC3; HT_HG-U133A | 5.50e-05 | 195 | 198 | 9 | 6695_UP | |
| Drug | Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; PC3; HT_HG-U133A | SPTAN1 MBNL1 TINAGL1 PRKD3 SLC12A6 TXNIP SLC7A1 MBNL2 RNF146 | 5.50e-05 | 195 | 198 | 9 | 3663_DN |
| Drug | Antazoline hydrochloride [2508-72-7]; Down 200; 13.2uM; HL60; HG-U133A | 5.95e-05 | 197 | 198 | 9 | 1556_DN | |
| Drug | Probenecid [57-66-9]; Down 200; 14uM; MCF7; HT_HG-U133A | 5.95e-05 | 197 | 198 | 9 | 4771_DN | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; PC3; HT_HG-U133A | 5.95e-05 | 197 | 198 | 9 | 4337_DN | |
| Drug | Asiaticoside [16830-15-2]; Down 200; 4.2uM; PC3; HT_HG-U133A | 6.19e-05 | 198 | 198 | 9 | 7244_DN | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 6.43e-05 | 199 | 198 | 9 | 5283_DN | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A | 6.43e-05 | 199 | 198 | 9 | 4297_DN | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 6.43e-05 | 199 | 198 | 9 | 3664_DN | |
| Drug | Stachydrine hydrochloride; Down 200; 22.2uM; HL60; HG-U133A | 6.43e-05 | 199 | 198 | 9 | 1751_DN | |
| Drug | NSC302991 | SETX CES2 MLH1 NCK2 RANGAP1 APAF1 NUP98 CASP7 CPT2 ATM TOP3A TP53BP1 | 6.56e-05 | 353 | 198 | 12 | CID000002538 |
| Drug | AC1NPJ0W | 7.14e-05 | 26 | 198 | 4 | CID005159169 | |
| Drug | bis(tri-n-butyltin)oxide | EPHB3 PSMA3 SPTAN1 RPS11 EZH2 UBA1 PI4KB TAX1BP1 HSPA5 DNMT1 GPD2 NELFA DUSP6 APAF1 CASP7 | 7.83e-05 | 538 | 198 | 15 | ctd:C005961 |
| Drug | eniluracil | 8.32e-05 | 27 | 198 | 4 | CID000043157 | |
| Drug | AC1L1KC5 | PRKD3 PIK3C2A ATP2C2 TRPV3 CACNA1G HSPA5 CACNA1A APAF1 CASP7 STEAP4 GRM4 IGF1 PRKCE LRBA ATP2B4 | 8.33e-05 | 541 | 198 | 15 | CID000005428 |
| Drug | mercury | HGF ZKSCAN7 ACSL1 PIK3C2A SUPT6H ATP2C2 CACNA1G CACNA1A SRSF7 STEAP4 LAP3 GBA3 IGF1 MAP2K2 ATP2B4 | 8.50e-05 | 542 | 198 | 15 | CID000023931 |
| Drug | Glafenine | RPS11 SRPRB STAT3 ACSL1 UBA1 UBR5 PUM3 C5 TMED10 C9 HSPA5 FLNA RANGAP1 DSP NLRX1 SMC6 STEAP4 CPT2 TRIM5 DENND6A GET4 MBNL2 GUCY1A1 ZNF436 RNF146 HSD17B10 | 9.03e-05 | 1327 | 198 | 26 | ctd:D005897 |
| Drug | monomethyl phthalate | HGF ARID1A EZH2 STAT3 CES2 MLH1 SLC12A6 TMEM182 UACA DSP DUSP6 CASP7 SKI GBA3 IGF1 GUCY1A1 LOXL2 TLN1 DMRTA1 HSD17B10 TOP3A | 9.66e-05 | 957 | 198 | 21 | ctd:C517284 |
| Drug | LY294002 | HGF PAK4 NOXA1 MYEF2 STAT3 PRKD3 PIK3C2A PI4KB C5 CASP7 IGF1 IGF2 NOM1 EIF4E PRKCE ATM LRBA MAP2K2 | 1.00e-04 | 748 | 198 | 18 | CID000003973 |
| Disease | Malignant neoplasm of breast | HK3 SPTAN1 ARID1A EZH2 STAT3 MFGE8 SEMA5B TAX1BP1 ZNF541 DNMT1 FLNA KIF6 SMC6 NUP98 CASP7 KMT2D IGF1 LOXL2 ZNF436 MACF1 ATM LRBA CPSF3 TP53BP1 | 2.24e-07 | 1074 | 196 | 24 | C0006142 |
| Disease | myotonic disease (implicated_via_orthology) | 2.89e-07 | 3 | 196 | 3 | DOID:450 (implicated_via_orthology) | |
| Disease | Cardiomyopathies | 2.67e-06 | 130 | 196 | 8 | C0878544 | |
| Disease | myotonic dystrophy type 2 (implicated_via_orthology) | 2.86e-06 | 5 | 196 | 3 | DOID:0050759 (implicated_via_orthology) | |
| Disease | myotonic dystrophy type 1 (implicated_via_orthology) | 5.69e-06 | 6 | 196 | 3 | DOID:11722 (implicated_via_orthology) | |
| Disease | nasopharynx carcinoma (is_marker_for) | 9.64e-06 | 43 | 196 | 5 | DOID:9261 (is_marker_for) | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 1.84e-05 | 169 | 196 | 8 | DOID:3908 (is_marker_for) | |
| Disease | Diffuse Large B-Cell Lymphoma | 3.26e-05 | 55 | 196 | 5 | C0079744 | |
| Disease | Hypertrophic Cardiomyopathy | 3.89e-05 | 57 | 196 | 5 | C0007194 | |
| Disease | dyslexia (implicated_via_orthology) | 4.39e-05 | 2 | 196 | 2 | DOID:4428 (implicated_via_orthology) | |
| Disease | alpha fetoprotein measurement | 5.65e-05 | 100 | 196 | 6 | EFO_0010583 | |
| Disease | Colonic Neoplasms | 7.36e-05 | 152 | 196 | 7 | C0009375 | |
| Disease | Malignant tumor of colon | 9.76e-05 | 159 | 196 | 7 | C0007102 | |
| Disease | rheumatoid arthritis (is_marker_for) | 9.78e-05 | 69 | 196 | 5 | DOID:7148 (is_marker_for) | |
| Disease | alcoholic neuropathy (biomarker_via_orthology) | 1.31e-04 | 3 | 196 | 2 | DOID:14183 (biomarker_via_orthology) | |
| Disease | meningioma (is_marker_for) | 1.31e-04 | 3 | 196 | 2 | DOID:3565 (is_marker_for) | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 1.31e-04 | 3 | 196 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 1.31e-04 | 3 | 196 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | T-Cell Lymphoma | 1.52e-04 | 16 | 196 | 3 | C0079772 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 1.52e-04 | 16 | 196 | 3 | C0334634 | |
| Disease | high grade glioma (is_marker_for) | 1.73e-04 | 42 | 196 | 4 | DOID:3070 (is_marker_for) | |
| Disease | hypertrophic cardiomyopathy (is_marker_for) | 1.83e-04 | 17 | 196 | 3 | DOID:11984 (is_marker_for) | |
| Disease | Liver Cirrhosis, Experimental | HGF SPTAN1 CD163 CES2 ACSL1 RMND5B FLNA DUSP6 APAF1 CASP7 STEAP4 SLC7A1 IGF1 LOXL2 SP140 | 2.23e-04 | 774 | 196 | 15 | C0023893 |
| Disease | Usual Interstitial Pneumonia | 2.59e-04 | 19 | 196 | 3 | C4721509 | |
| Disease | Hamman-Rich Disease | 2.59e-04 | 19 | 196 | 3 | C4721508 | |
| Disease | congenital disorder of glycosylation Ia (is_marker_for) | 2.61e-04 | 4 | 196 | 2 | DOID:0080552 (is_marker_for) | |
| Disease | Breast Carcinoma | ARID1A EZH2 STAT3 MFGE8 DNMT1 FLNA CASP7 KMT2D IGF1 LOXL2 ATM TP53BP1 | 2.75e-04 | 538 | 196 | 12 | C0678222 |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 3.03e-04 | 20 | 196 | 3 | C4721952 | |
| Disease | Idiopathic Pulmonary Fibrosis | 3.51e-04 | 21 | 196 | 3 | C1800706 | |
| Disease | Bipolar Disorder | MFGE8 NRXN1 STARD9 HSPA5 DNMT1 CACNA1A SLC12A6 DUSP6 GRM4 IGF1 DCLK1 | 3.73e-04 | 477 | 196 | 11 | C0005586 |
| Disease | stomach cancer (is_marker_for) | 3.85e-04 | 142 | 196 | 6 | DOID:10534 (is_marker_for) | |
| Disease | Other restrictive cardiomyopathy | 4.33e-04 | 5 | 196 | 2 | C0348616 | |
| Disease | Malignant Cystosarcoma Phyllodes | 4.33e-04 | 5 | 196 | 2 | C0600066 | |
| Disease | Lupus Erythematosus, Discoid | 4.33e-04 | 5 | 196 | 2 | C0024138 | |
| Disease | Phyllodes Tumor | 4.33e-04 | 5 | 196 | 2 | C0010701 | |
| Disease | lung carcinoma (implicated_via_orthology) | 4.33e-04 | 5 | 196 | 2 | DOID:3905 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 4.60e-04 | 96 | 196 | 5 | C1319315 | |
| Disease | Immunologic Deficiency Syndromes | 4.63e-04 | 23 | 196 | 3 | C0021051 | |
| Disease | breast cancer (is_implicated_in) | 5.15e-04 | 150 | 196 | 6 | DOID:1612 (is_implicated_in) | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 5.27e-04 | 24 | 196 | 3 | DOID:3827 (biomarker_via_orthology) | |
| Disease | colon cancer (is_marker_for) | 6.46e-04 | 59 | 196 | 4 | DOID:219 (is_marker_for) | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 6.47e-04 | 6 | 196 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | retinopathy of prematurity (is_marker_for) | 6.47e-04 | 6 | 196 | 2 | DOID:13025 (is_marker_for) | |
| Disease | Noonan syndrome (is_marker_for) | 6.47e-04 | 6 | 196 | 2 | DOID:3490 (is_marker_for) | |
| Disease | migraine with aura (is_implicated_in) | 6.47e-04 | 6 | 196 | 2 | DOID:10024 (is_implicated_in) | |
| Disease | Streptozotocin Diabetes | 7.88e-04 | 108 | 196 | 5 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 7.88e-04 | 108 | 196 | 5 | C0011853 | |
| Disease | Alloxan Diabetes | 7.88e-04 | 108 | 196 | 5 | C0002152 | |
| Disease | Mammary Carcinoma, Human | EZH2 STAT3 MFGE8 DNMT1 FLNA CASP7 KMT2D IGF1 LOXL2 ATM TP53BP1 | 8.23e-04 | 525 | 196 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | EZH2 STAT3 MFGE8 DNMT1 FLNA CASP7 KMT2D IGF1 LOXL2 ATM TP53BP1 | 8.23e-04 | 525 | 196 | 11 | C1257931 |
| Disease | Mammary Neoplasms | EZH2 STAT3 MFGE8 DNMT1 FLNA CASP7 KMT2D IGF1 LOXL2 ATM TP53BP1 | 8.49e-04 | 527 | 196 | 11 | C1458155 |
| Disease | Nemaline Myopathy, Childhood Onset | 9.02e-04 | 7 | 196 | 2 | C0546125 | |
| Disease | neutropenia (implicated_via_orthology) | 9.02e-04 | 7 | 196 | 2 | DOID:1227 (implicated_via_orthology) | |
| Disease | Neoplasms, Experimental | 9.86e-04 | 66 | 196 | 4 | C0027659 | |
| Disease | Cardiomyopathies, Primary | 1.17e-03 | 69 | 196 | 4 | C0033141 | |
| Disease | Myocardial Diseases, Secondary | 1.17e-03 | 69 | 196 | 4 | C0036529 | |
| Disease | Sudden Cardiac Arrest | 1.20e-03 | 8 | 196 | 2 | C1720824 | |
| Disease | Sudden Cardiac Death | 1.20e-03 | 8 | 196 | 2 | C0085298 | |
| Disease | Spinocerebellar Ataxia Type 2 | 1.48e-03 | 34 | 196 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 1.48e-03 | 34 | 196 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 1.48e-03 | 34 | 196 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 1.48e-03 | 34 | 196 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 1.48e-03 | 34 | 196 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 1.48e-03 | 34 | 196 | 3 | C0087012 | |
| Disease | Neoplasm Invasiveness | 1.49e-03 | 184 | 196 | 6 | C0027626 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 1.51e-03 | 74 | 196 | 4 | DOID:3748 (is_marker_for) | |
| Disease | familial hypertrophic cardiomyopathy (is_implicated_in) | 1.53e-03 | 9 | 196 | 2 | DOID:0080326 (is_implicated_in) | |
| Disease | uveal melanoma (is_marker_for) | 1.53e-03 | 9 | 196 | 2 | DOID:6039 (is_marker_for) | |
| Disease | Spinocerebellar Ataxia Type 4 | 1.62e-03 | 35 | 196 | 3 | C0752122 | |
| Disease | IGF-1 measurement | ARID1A STARD9 DNMT1 NUP98 KIF7 IGF1 IGF2 RNF146 DMRTA1 MYBPC3 | 1.66e-03 | 488 | 196 | 10 | EFO_0004627 |
| Disease | human immunodeficiency virus infectious disease (is_marker_for) | 1.75e-03 | 36 | 196 | 3 | DOID:526 (is_marker_for) | |
| Disease | brain ischemia (is_implicated_in) | 1.91e-03 | 10 | 196 | 2 | DOID:2316 (is_implicated_in) | |
| Disease | Antihypertensive use measurement | 2.05e-03 | 265 | 196 | 7 | EFO_0009927 | |
| Disease | Liver carcinoma | 2.19e-03 | 507 | 196 | 10 | C2239176 | |
| Disease | uterine fibroid | 2.21e-03 | 199 | 196 | 6 | EFO_0000731 | |
| Disease | Alveolitis, Fibrosing | 2.30e-03 | 83 | 196 | 4 | C4721507 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 2.32e-03 | 11 | 196 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Copper-Overload Cirrhosis | 2.32e-03 | 11 | 196 | 2 | C1876165 | |
| Disease | Lymphoma | 2.38e-03 | 40 | 196 | 3 | C0024299 | |
| Disease | Arthritis, Collagen-Induced | 2.38e-03 | 40 | 196 | 3 | C0971858 | |
| Disease | Arthritis, Experimental | 2.38e-03 | 40 | 196 | 3 | C0993582 | |
| Disease | Arthritis, Adjuvant-Induced | 2.38e-03 | 40 | 196 | 3 | C0003865 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.41e-03 | 139 | 196 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | pulse pressure measurement | MBNL1 SVEP1 STAT3 NSD3 PRKD3 PIK3C2A SUPT6H MYPN DNMT1 TMEM161B OTUB1 ARHGEF12 FHOD3 GRM4 GUCY1A1 EIF4E PRKCE MAP2K2 MYBPC3 | 2.43e-03 | 1392 | 196 | 19 | EFO_0005763 |
| Disease | Pulmonary Fibrosis | 2.51e-03 | 85 | 196 | 4 | C0034069 | |
| Disease | Malignant neoplasm of liver | 2.64e-03 | 142 | 196 | 5 | C0345904 | |
| Disease | Liver neoplasms | 2.64e-03 | 142 | 196 | 5 | C0023903 | |
| Disease | Colorectal Carcinoma | HK3 ARID1A MLH1 FLNC AMPD1 ADAM29 IGF2 PANK4 PRKCE DMRTA1 DCLK1 EPHA7 | 2.69e-03 | 702 | 196 | 12 | C0009402 |
| Disease | inflammatory bowel disease (is_marker_for) | 2.77e-03 | 12 | 196 | 2 | DOID:0050589 (is_marker_for) | |
| Disease | Charcot-Marie-Tooth Disease | 2.77e-03 | 12 | 196 | 2 | C0007959 | |
| Disease | depressive symptom measurement, response to antidepressant | 2.85e-03 | 88 | 196 | 4 | EFO_0007006, GO_0036276 | |
| Disease | Prostatic Neoplasms | ARID1A EZH2 HNRNPH1 STAT3 MLH1 DNMT1 STEAP4 SLC7A1 KMT2D IGF1 ATM | 2.89e-03 | 616 | 196 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | ARID1A EZH2 HNRNPH1 STAT3 MLH1 DNMT1 STEAP4 SLC7A1 KMT2D IGF1 ATM | 2.89e-03 | 616 | 196 | 11 | C0376358 |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 3.07e-03 | 147 | 196 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | Familial dilated cardiomyopathy | 3.13e-03 | 44 | 196 | 3 | C0340427 | |
| Disease | Common variable immunodeficiency | 3.26e-03 | 13 | 196 | 2 | cv:C0009447 | |
| Disease | prostate carcinoma (is_implicated_in) | 3.26e-03 | 13 | 196 | 2 | DOID:10286 (is_implicated_in) | |
| Disease | Gastric Adenocarcinoma | 3.34e-03 | 45 | 196 | 3 | C0278701 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.54e-03 | 152 | 196 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Myocardial Infarction | 3.75e-03 | 95 | 196 | 4 | C0027051 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KVLTLNVGDEFCGVV | 486 | Q9BXT4 | |
| NVKRCGNGVVEEGEE | 396 | Q9UKF5 | |
| DKNSGILTRECGNEF | 1771 | O00555 | |
| AGCGKSVLAAEAVRD | 156 | O14727 | |
| GKENFRERGSEEICV | 1286 | A6H8Y1 | |
| RTFDKQCDDLIGRGS | 216 | Q6NVV9 | |
| TDKRNGVIIAGYCVE | 346 | Q9UKF6 | |
| DEEAVVDFKAVQGRC | 1046 | P26358 | |
| CGEFVEGEVVTALGK | 161 | O14639 | |
| GFEGSFEELCRNKDV | 616 | P33121 | |
| GSCVDFLIRKGAEVD | 91 | Q9Y576 | |
| EAFIQKSREDGGVCI | 236 | Q14833 | |
| QEVTLERAGKAEACF | 161 | Q96QA5 | |
| EELSGLGEKCRSFID | 111 | Q6UXU4 | |
| FGSIGEIESCKLVRD | 71 | P26378 | |
| CDQFIEGEVVSALGK | 86 | Q6H8Q1 | |
| SGVTVEDFEIVCKGL | 126 | P23109 | |
| VGNKTECALLGFVTD | 531 | P23634 | |
| EFSNVSVGKLVEAGC | 426 | O75185 | |
| RCVIIQKDDNGFGLT | 71 | Q9NZN5 | |
| TLGEGAFGKVVECID | 166 | P49759 | |
| LTIDCVQFQRGGKEF | 441 | P23786 | |
| LVNSRGEIKLCDFGV | 201 | P36507 | |
| DFGLVCRNREQVGKF | 4196 | Q9HC84 | |
| VEVINFGDCLVRSKG | 266 | P46060 | |
| DSGVGKTCLIIRFAE | 16 | P51153 | |
| AVGEEEVPKCSFREA | 191 | Q9H0G5 | |
| EDLGFRQGDTVDVLC | 416 | Q86UR1 | |
| EKFGGSFLNCVRESE | 161 | Q5T6V5 | |
| NGREGCFAKTLVEHV | 571 | Q15397 | |
| QELELEGTGVCFSKQ | 116 | Q6NTE8 | |
| DCSDKLGRVQEFDSG | 1826 | O14497 | |
| VRGLGTEKEDSCFEL | 196 | Q9H765 | |
| EGKENIRAAVAAGCR | 116 | P28838 | |
| CEVEKHGRGQVLFDL | 111 | Q9H4G0 | |
| EKGECIVSDFTIGRK | 756 | P52948 | |
| SGARCKDVLTGQEFD | 266 | P43304 | |
| DAGKRDDFIGRCQVD | 541 | Q6DN14 | |
| GQTVGESCQELREKF | 126 | Q567V2 | |
| RDSQGNCFIDRDGKV | 41 | Q4G0X4 | |
| LGELREKVGECEASA | 121 | Q9H3P2 | |
| ECALNERGVEGDFLI | 296 | O43639 | |
| QAKEIFSTCLEGEQG | 401 | Q14439 | |
| GLCEEISQEVRGDVF | 36 | Q08431 | |
| EGRVCKVRFDANGAT | 361 | Q16538 | |
| NCGVDARGIAKVLAD | 291 | Q02156 | |
| EVGEGVTFERFIVQC | 306 | Q9UI26 | |
| EVFEQCGEIIAIRKS | 146 | Q16206 | |
| DNGRTCKAGAEEVLL | 331 | O75197 | |
| SDDVCGAVVNVRAKG | 146 | P06730 | |
| SVVCRELGFGSAKEA | 361 | Q9Y4K0 | |
| EAAAGGKVLREENQC | 6 | Q8WYA1 | |
| IGDGNFAVVKECVER | 396 | O15075 | |
| GDGNFAVVKECIDRS | 401 | Q8N568 | |
| VIGDGNFAVVKECRH | 361 | Q9C098 | |
| CGDVEGKFDILFNRV | 11 | Q69YN2 | |
| KVHGDRECGFINDEI | 156 | Q15910 | |
| GCSKEEIVQFFSGLE | 121 | P55795 | |
| SLETGVGDQCRKEFT | 1296 | Q9ULL4 | |
| VAAVREVCEEAGVKG | 61 | O95989 | |
| DVGSYVLKVCGQEEV | 466 | O00443 | |
| DQVDSEALVGCLRGK | 281 | O00748 | |
| ERGKVGEAATFTVDC | 1166 | Q14315 | |
| DERGNVVLCGVKEVD | 171 | Q2M1P5 | |
| QGTGRFDVCDVNARK | 736 | Q6ZMV9 | |
| KVPRDCLGEVTFNGE | 316 | O94806 | |
| FREQQGKVDEEIGLC | 936 | P50851 | |
| CQGRVVAAEEKNGVV | 521 | Q9UL01 | |
| SCVKIEEVIGAGEFG | 631 | P54753 | |
| LVAEEGGFAVVCKDR | 136 | Q9UGL1 | |
| TLNESEICAGAEKIG | 651 | P14210 | |
| GCSKEEIVQFFSGLE | 121 | P31943 | |
| GCLEAGIRTEEEFQL | 451 | Q86UT6 | |
| VGCIRDLFIDGQSKD | 641 | Q9ULB1 | |
| GCRKDNFDIAEGVRT | 236 | P29728 | |
| SCIKIERVIGAGEFG | 631 | Q15375 | |
| KGFRCSGVEGQDVVQ | 186 | P52790 | |
| KFGRVDVAVNCAGIA | 81 | Q99714 | |
| EQKECRAVAGVIDLG | 1541 | Q9UPN3 | |
| SEIFGTCGEEQKTVL | 5736 | Q9UPN3 | |
| KVALGDTCVEDVAFQ | 861 | Q7Z442 | |
| CFEEALDGVVKRAVA | 451 | Q9NVE7 | |
| EHFIEGGRTVKEFCQ | 191 | Q96FW1 | |
| GGRTVKEFCQQEVEP | 196 | Q96FW1 | |
| VRECGIEKHQSSIGF | 666 | Q13315 | |
| VIGNECQKVFDGVDA | 1641 | Q3L8U1 | |
| GKQSDIFLGDRVERC | 281 | Q8NHM5 | |
| ILRVGVTANFFCDEG | 231 | P20023 | |
| GAATISCRNEEGKAV | 26 | Q8WZ79 | |
| GVGAGCNTKEVIDRL | 116 | Q15329 | |
| RCAVGLVDAVKATDQ | 71 | Q8WTW3 | |
| GKFFVCQGEDTRNIT | 1436 | O43497 | |
| ERVFKNQTGDVACGS | 41 | Q9H227 | |
| GPFNRDVVEGCVKET | 116 | Q6ZN84 | |
| FEVKVGTECGNQKVR | 566 | P21333 | |
| AEISFEDRKDGSCGV | 2281 | P21333 | |
| EDRKDGSCGVAYVVQ | 2286 | P21333 | |
| ERVFQFLEKSDLGCG | 621 | P01031 | |
| VGERIKDFLQGSSCI | 2246 | P15924 | |
| EREPVGTCFLQDGTK | 151 | P06756 | |
| EGILRFCKGDVVQAI | 346 | Q5VZB9 | |
| VGCLDNRGSVKAFAE | 736 | Q2V2M9 | |
| ELVDTLQFVCGDRGF | 36 | P01344 | |
| FRVDRKDDGGIIICE | 186 | Q8NFZ8 | |
| CVVGFDLELGQAVEV | 66 | Q8IWF6 | |
| VTQLLKDTCFEGGDI | 21 | P03951 | |
| FFIQACRGTELDDGI | 181 | P55210 | |
| GICVVDDFLGKETGQ | 206 | Q9GZT9 | |
| TEKLQRCEKIGEGVF | 481 | Q8TF76 | |
| RCEKIGEGVFGEVFQ | 486 | Q8TF76 | |
| ENGRVIACFDSLKGR | 46 | Q9NR56 | |
| ENGRVIACFDSLKGR | 46 | Q5VZF2 | |
| VENGRVVACFDSLKG | 46 | Q9NUK0 | |
| DAREFIDKQVCGTPE | 531 | O60307 | |
| NSGARVVICDKDESG | 31 | Q9BPX1 | |
| VVICDKDESGGRALE | 36 | Q9BPX1 | |
| DVVVSDECRGKQLGK | 121 | Q96EK6 | |
| AELVDALQFVCGDRG | 56 | P05019 | |
| PEGKNAVFRAVVCGE | 41 | Q86VF2 | |
| CVGVFKNGRVEIIAN | 41 | P11021 | |
| GENKCSGRVEVKVQE | 56 | Q86VB7 | |
| ISFIDEARGKNCGVL | 276 | Q16828 | |
| CIEGVVLRDKFGDAV | 541 | Q9UHW9 | |
| VDEAGVICKQEGIFR | 441 | Q9Y2H2 | |
| SIEVFGQFNGKRCTD | 66 | P02748 | |
| DGRVKLSDFGFCAQV | 451 | O96013 | |
| DRCLADAVVKIGTGF | 11 | Q5TGZ0 | |
| CFRDVQIGDIVTVGE | 116 | P62280 | |
| GCTKEEIVQFFSGLE | 121 | P52597 | |
| QVDDGRKIVFVPGCS | 356 | P54136 | |
| VEFLECSAKGGRGDV | 241 | Q9Y5M8 | |
| RGVNECDIESFVLGV | 441 | Q9GZM7 | |
| AAEADFDIVTKGQVC | 511 | Q86VP1 | |
| RGKDAAEIVLEAFCA | 576 | Q96R06 | |
| GEVTEECGKFGAVNR | 481 | Q9UHX1 | |
| KVEDGGERSVCVTFG | 161 | Q8NDZ6 | |
| AVDGGKLTVFTVLCE | 246 | Q7L5D6 | |
| RGCGVVEFKDEEFVK | 141 | Q9P2K5 | |
| LEDVKTVVCRNVAGG | 226 | Q8IXI1 | |
| LGNEVSDEECLKRVG | 371 | Q8NFW8 | |
| CSEQDVIVSGAEGKL | 311 | Q7RTZ1 | |
| NGRVDEAVSLGFLDC | 36 | A1A4F0 | |
| ERCIKVFLHENGEEG | 2746 | Q96Q15 | |
| TVANVGDSRGVLCDK | 206 | Q5SGD2 | |
| CGFNINVRDFEGKVV | 41 | Q9P1U0 | |
| VDTVDAFQGRQKDCV | 2371 | Q7Z333 | |
| LFIGVDDKSREVLGC | 246 | Q7Z7L1 | |
| KGVAGLRLDCDANTV | 176 | Q9NTX7 | |
| NGGIDEEDIRFLCVT | 1686 | Q9UPS6 | |
| GSEGKECDNLFTVIA | 456 | Q5C9Z4 | |
| NSEGKDFCGGVIIRE | 196 | P22891 | |
| GCQILDAGREEVAVA | 3241 | Q9P2P6 | |
| IGAQFKIEVDEGFCS | 876 | Q9UHV7 | |
| LDIIGRNTDCGKEAE | 1146 | Q9UHV7 | |
| GNAVSRELIEIGCED | 221 | P40692 | |
| ELVNGDGVDSEIRCL | 76 | Q9UBF8 | |
| EDGRGCEVIQEIKSF | 66 | P10155 | |
| TVNGTDFDCGKAARI | 3016 | Q4LDE5 | |
| EGETISCFVVGGEKR | 106 | P12755 | |
| VVGCDRGKILFVSES | 161 | O00327 | |
| CALVNGEGEVTDFLR | 796 | Q7KZ85 | |
| EIQGGDVRTACFLFE | 981 | A4UGR9 | |
| DIQGGDVRKGCFIFE | 1091 | A4UGR9 | |
| VIGLEEGVKCSAFQD | 401 | Q9C035 | |
| LIKGFGCRGAQVEEI | 21 | Q9Y5K5 | |
| GSEEVRKVNCYGQEV | 206 | O43829 | |
| IKVAVDRSCDIGNFE | 566 | A6PVC2 | |
| NECGRGFSERSDLIK | 281 | Q9C0F3 | |
| FKQGEDAEVVCRVSS | 126 | O15394 | |
| EVCFESKGTGRIPDQ | 106 | P49755 | |
| DCINTIRQEEGVFGF | 371 | Q96AG3 | |
| KAIDRNFDSEICGVV | 91 | Q96G75 | |
| GVRGASKEVVELGFC | 216 | C9JR72 | |
| FVGFDCIATTGEEVK | 266 | P30825 | |
| GTEAEACREGKVSVE | 356 | Q9H7N4 | |
| LVEAGRLVAKAVEGC | 736 | Q9Y490 | |
| VCIDKDSGDVAALRG | 366 | P40763 | |
| LIERGACAGSEDAVK | 1616 | Q13813 | |
| SAEQGEVENGRCITK | 21 | Q86SZ2 | |
| EDAVRGLDGKVICGS | 61 | Q16629 | |
| GDFGSSRLIEKECLE | 171 | Q8IX01 | |
| CVEKEERFQSIAGLS | 251 | Q96SB8 | |
| SEKQETVCIFGTGDF | 16 | Q687X5 | |
| TAIGIRCKDGVVFGV | 36 | P25788 | |
| VCKNDVGGRFLLEDT | 321 | Q9P283 | |
| ATGCKGREETVAEDV | 601 | Q12888 | |
| GEFCHNRGIKLVVAD | 176 | P22314 | |
| CERKEGSQFGETISQ | 71 | Q8N972 | |
| TVNGDVRVGLFALCD | 1236 | Q9BZ95 | |
| REGENIGFEIIHVCK | 151 | Q13472 | |
| FKGDVACQVLESERA | 1451 | Q8IUG5 | |
| GCRDAVEVLIKNGAD | 211 | Q9BZF9 | |
| LEVCRAFLQEDKGEG | 256 | Q9H5U6 | |
| TGDVCEDTFKELEGQ | 311 | Q9P0L1 | |
| EECGKAFIRGSQLTQ | 366 | Q8TAQ5 | |
| KRIFAAVSEGCVEEL | 121 | Q8NET8 | |
| GVSCKLAIQIDEGES | 221 | Q13342 | |
| GCSDNVEFGERISKL | 131 | Q9H1J5 | |
| GEKGSVCGAVDRLSV | 216 | Q658N2 | |
| RVQADSKECGEGLRF | 951 | Q9C0I4 | |
| SARIDRKGFCEGDEI | 181 | Q9H3M7 | |
| IFVLGAEDGCISTKE | 26 | P63316 | |
| VGRCSGEKNIENVTF | 36 | Q6ZP80 | |
| VDDTFRIKCGSVDFG | 251 | Q9H267 | |
| TAEDFRLLVNGCGEV | 2671 | O95071 | |
| GSCEARAGAKEVSVI | 16 | Q6ZVH6 | |
| LDQVDGSFGICVVKD | 1031 | Q9H0D2 | |
| QCGELDVYKVETIGD | 516 | Q02108 | |
| ELCGVDKAIFSGISQ | 156 | O14686 | |
| QAVFKCEVSDENVRG | 561 | Q14896 | |
| ASEGQLVVFECRVKG | 446 | Q86TC9 |